書籍詳細

第1章 分子生物学

P.3 掲載の参考文献

• 1) Seidman MD et al:The protective effects of allopurinoland superoxide dismutase on noise-induced cochlear damage. Otolaryngol Head Neck Surg 109:1052-1056, 1993
  pubmed

• 2) Otto WC et al:Effects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs. Hear Res 35:79-85, 1988
  pubmed

• 3) Garetz SL:Sulfhydryl compounds and antioxidants inhibit cytotoxicity to outer hair cells of a gentamicin metabolite in vitro. Hear Res 77:75-80, 1994
  pubmed

• 4) Ohlemiller KK et al:Targeted deletion of the cytosolic Cu/Zn superoxide dismutase gene (Sod1) increases susceptibility to noise-induced hearing loss. Audiol Neurootol 4:237-246, 1999
  pubmed

• 5) Sha SH et al:Overexpression of copper/zinc-superoxide dismutase protects from kanarnycin-induced hearing loss. Audiol Neurootol 6:117-123, 2001
  pubmed

• 6) Horiike O et al:Protective effect of edaravone against streptomycin-induced vestibulotoxicity in the guinea pig. Eur J Phanmacol 464:75-78, 2003
  pubmed

• 7) Davis RJ:Signaltransduction by the JNK group of MAP kinases. Cell 103:239-252, 2000

• 8) Harper SJ et al:Signalling for survivaland death in neurones:the role of stress-activated kinases, JNK and p 38. Cell Signal 13:299-310, 2001

• 9) Pirvola U et al:Rescue of hearing, auditory hair cels, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation. J Neurosci 20:43-50, 2000

• 10) Ylikoski J et al:Blockade of c-Jun N-terminal kinase path-way attenuates gentamicin-induced cochlear and vestibular hair celldeath. Hear Res 163:71-81, 2002

• 11) Bodmer D et al:Rescue of auditory hair cells from aminoglycoside toxicity by Clostridium difficile toxin B, an inhibitor of the small GTPases Rho/Rac/Cdc 42. Hear Res 172:81-86, 2002

• 12) Wang J et al:Apeptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair celldeath and hearing loss. J Neurosci 23:8596-8607, 2003

• 13) Liu W et al:Caspase inhibitors prevent cicplatin-induced apoptosis of auditory sensory cells. Neuro Report 9:2609-2614, 1998

• 14) Cheng AG et al:Calpain inhibitors protect auditory sensory cells from hypoxia and neurotrophin-withdrawa linduced apoptosis. Brain Res 850:234-243, 1999

• 15) Forge A et al:Apoptotic death of hair cells in mammalian vestibular sensory epithelia. Hear Res 139:97-115, 2000
  pubmed

• 16) Matsui J et al:Inhibition of caspase prevents ototoxic and ongoing hair celldeath. J Neurosci 22:1218-1227, 2002

• 17) Cheng AG et al:Hair celldeath in the avian basilar papilla:characterization of the in vitro modeland caspase activation. J Assoc Res Otolaiyngol 4:91-105, 2003

• 18) Cunningham LL et al:Caspase activation in hair cells of the mouse utricle exposed to neomycin. J Neurosci 22:8532-8540, 2002
  pubmed

• 19) Lee JE et al:Signaling pathway for apoptosis of vestibular hair cells of mice due to aminoglycosides. Acta Otolaryngol Suppl 551:69-74, 2004
  pubmed

• 20) Okuda T et al:Inhibition of caspases alleviates gentamicin-induced cochlear damage in guinea pigs. Auris Nasus Laiynx 32:33-37, 2005
  pubmed

• 21) Takahashi K et al:Caspase-3-deficiency induces hypenyplasia of supporting cells and degeneration of sensory cells resulting in the hearing loss. Brain Res 894:359-367, 2001
  pubmed

• 22) Morishita H et al:Deafness due to degeneration of cochlear neurons in caspase-3-deficient mice. Biochem Biophys Res Commun 284:142-149, 2001
  pubmed

• 23) Hartl FU:Molecular chaperones in celler protein folding. Nature 381:571-580, 1996

• 24) Agashe VR et al:Role of molecular chaperones in cytoplasmic protein folding. Semin. Cell Dev. Biol 11:15-25, 2000

• 25) Mosser DD et al:Role of the human heat shock protein hsp 70 in protection against stress-induced apoptosis. Mol Cell Biol 17:5317-5327, 1997
  pubmed

• 26) Jiiattela M et al:Hsp 70 exerts its anti-apoptotic function dowmstream of caspase-3-like proteases. EMBO J 17:6124-6134, 1998

• 27) Beere HM et al:Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2:469-475, 2000

• 28) Tsuchiya D et al:Overexpression of rat heat shock protein 70 is associated with reduction of early mitochondrialcytochrome C release and subsequent DNA fragmentation after permanent focalischemia. J Cereb Blood Flow Metab 23:718-727, 2003

• 29) Inouye S et al:Activation of heat shock genes is not necessary for protection by heat shock transcription factor lagainst cell death due to a single exposure to high temperatures. Mol Cell Biol 23:5882-5895, 2003

• 30) Neely JG et al:Detection and localization of heat shock protein 70 in the normalguinea pig cochlea. Hear Res 52:403-406, 1991
  pubmed

• 31) Akizuki H et al:Nuclear transition of heat shock protein in guinea pig cochlea after hyperthenmia. Hear Res 92:126-130, 1995
  pubmed

• 32) Lim HH et al:Detection of HSP 72 synthesis after acoustic overstimulation in rat cochlea. Hear Res 69:146-150, 1993
  pubmed

• 33) Myers MW et al:Expression of the major mammalian stress protein in the rat cochlea following transient ischemia. Laryngoscope 102:981-987, 1992
  pubmed

• 34) Oh SH et al:Expression of heat shock protein 72 in rat cochlea with cisplatin-induced acute ototoxicity. Acta Otolaryngol 120:146-150, 2000
  pubmed

• 35) Fairfield DA et al:Expression and localization of heat shock factor (Hsf) 1 in the rodent cochlea. Hear Res 173:109-118, 2002
  pubmed

• 36) Ybshida N et al:Heat stress and protection from permanent acoustic injury in mice. J Neurosci 19:10116-10124, 1999

• 37) Sugahara K et al:Heat shock transcription factor HSF1 is required for survivalof sensory hair cells against acoustic over exposure. Hear Res 182:88-96, 2003

第2章 再生医療

P.14 掲載の参考文献

• 1) Stone JS et al:Cellular studies of auditory hair cell regeneration in birds. Proc Natl Acad Sci U S A 97:11714-11721, 2000
  pubmed

• 2) Nakagawa T et al:Application of cell therapy to inner ear diseases. Acta Otolaryngol Mar, 551 (Suppl):6-9, 2004
  pubmed

• 3) Sage C et al:Proliferation of functional hair cells in Vivo in the absence of the retino blastoma protein. Science 307:1114-1118, 2005

• 4) Kawamoto K et al:Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther 9:173-181, 2004
  pubmed

• 5) Kawamoto K et al:Hearing and hair cells are protected by adenoviralgene therapy with TGF-betaland GDNF. Mol Ther 7:484-492, 2003

• 6) Nakaizumi T et al:Adenovirus-mediated expression of brainderived neurotrophic factor protects spiralganglion neurons from ototoxic damage. Audiol Neurooto 19:135-143, 2004

• 7) Lalwani AK et al:Development of in vivo gene therapy for hearing disorders:introduction of adeno-associated virus into the cochlea of the guinea pig. Gene Ther 3:588-592, 1996
  pubmed

• 8) Kawamoto K et al:The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice. Mol Ther 4:575-585, 2001
  pubmed

• 9) Stover T et al:Cochlear gene transfer:round window versus cochleostomy inoculation. Hear Res 136:124-130, 1999
  pubmed

• 10) Ishimoto S et al:Gene transfer into supponing cells of the organ of Corti. Hear Res 173:187-197, 2002
  pubmed

• 11) Suzuki M et al:A denoviral vector gene delivery Via the round window membrane in guinea pigs. Neuroreport 14:1951-1955, 2003

• 12) Chen P et al:The role of Mathlin inner ear development:Uncoupling the establishment of the sensory primordium from hair cellfate determination. Development 129:2495-2505, 2002

• 13) Shou J et al:Robust generation of new hair cells in the mature mammalian inner ear by adenoviralexpression of Hath 1. Mol Cell Neurosci 23:169-179, 2003

• 14) Kawamoto K et al:Mathlgene transfer generates new cochlear hair cells in mature guinea pigs in Vivo. J Neurosci 23:4395-4400, 2003
  pubmed

• 15) Izumikawa M et al:Auditory hair cell replacement and hearing improvement by Atohlgene therapy in deaf mammals. Nat Med 11:271-276, 2005
  pubmed

P.18 掲載の参考文献

• 1) Nibu K:Introduction to olfactory neuroepitehlium. Micro Res Tech 58:133-134, 2002

• 2) 丹生健一:嗅上皮の構造と機能.耳鼻臨床 96:847-854, 2003

• 3) Calof AL et al:Progenitor cells of the olfactory receptor lineage. Micro Res Tech 58:176-188, 2002

• 4) Cau E et al:Mashlactivates a cascade of BHLH regulators in olfactoly neuron progenitors. Development 124:1611-1621, 1997
  pubmed

• 5) Nibu K et al:Expression of Neuro D and Trk B in developing and aged mouse olfactoiy epithelium. Neuro Report 12:1615-1619, 2001

• 6) Doi K et al:Notch expression in developing olfactory neuroepithelium. Neuro Report 15:945-947, 2004

• 7) Miwa T et al:Trk A expression in mouse olfactory tract following axotomy of olfactory nerves. Acta Oto-laiyngol(suppl) 539:79-82, 1998

• 8) Newman et al:Growth factor regulation of neurogenesis in adult olfactory epithelium. Neuroscience 99:343-350, 2000
  pubmed

• 9) Buckland ME et al:Alterations in expression of the neurotrophic factors, glial cell line-derived neurotrophic factor, ciliary neurotrophic factor and brain-derived neurotrophic factor, in target-derived olfactory neuroepithelium. Neuroscience 90:333-347, 1999
  pubmed

• 10) Cowan MC et al:Apoptosis in the mature and developing olfactory neuroepithelium. Micro Res Tech 58:204-215, 2000

• 11) Ohta Y et al:High-dose glucocorticoids inhibit proliferation of rat olfactory epithelium. Ann Otol Rhinol Laryngol 111:909-911, 2000

• 12) Yasuno H et al:Nerve growth factor applied onto the olfactory epithelium alleviates degenerative changes of the olfactory receptor neurons following axotomy. Brain Res 887 (1):53-62, 2000
  pubmed

• 13) Isoyama K et al:Effects of adenoviralvector-mediated BDNF expression on the bulbectomy-induced apoptosis of olfactory receptor neurons. Brain Res Mol Brain Res 129 (1-2):88-95, 2004

• 14) Doi K et al:Adenovirus-mediated gene transfer in olfactory epithelium and olfactory bulb. Ann Otol Rhinol Laryngol(in press) 2005

第3章 再建医療

P.22 掲載の参考文献

• 1) Andersen JG:Surgical treatment of lagophthalmos in leprosy by the Gillies temporalis transfer. Br J Plast Surg 14:339-345, 1961
  pubmed

• 2) Owens N:Surgical correction of facial paralysis. Plast Re-constr Surg 2:25-31, 1947

• 3) Rubin LR:Reanimation of congenital facial paralysis, including Mobius syndrome. The Paralyzed Face. Rubin LR (ed), Mosby, St Louis, 213-219, 1991

• 4) Harii K et al:Free gracilis muscle transplantation, with micro neurovascular anastomoses for the treatment of facialparalysis. A preliminary report. Plast Reconstr Surg 57:133-143, 1976

• 5) O' Brien BM et al:Results of management of facial palsy With microvascular free-muscle transfer. Plast Reconstr Surg 86:12-22, 1990
  pubmed

• 6) Terzis J et al:Analysis of 100 cases of free-muscle transplantation for facial paralysis. Plast Reconstr Surg 99:1905-1921, 1997
  pubmed

• 7) Harii K:Refined microneurovascular free muscle transplantation for reanimation of paralyzed face. Microsurgery 9:169-176, 1988
  pubmed

• 8) Harrison DH:The pectoralis minor vascularized muscle graft for the treatment of unilateralfacialpalsy. Plast Reconstr Surg 75:206-216, 1985
  pubmed

• 9) Dellon AL et al:Segmentally innervated latissimus dorsi muscle. Microsurgical transfer for facialre-animation. J Reconstr Microsurg 2:7-12, 1985
  pubmed

• 10) Harii K et al:One-stage transfer of the latissimus dorsi muscle for re-animation of a paralyzed face:a new alternative. Plast Reconstr Surg 102:941-951, 1998

• 11) 波利井清紀:顔面神経麻痺の治療における神経,筋肉移植の基礎と臨床.日本形成外科学会誌 7:347-372, 1987

• 12) Taknshima A et al:Neurovascular free-muscle transfer for the treatment of established facialparalysis following ablative surgery in the parotid region. Plast Reconstr Surg 113:1563-1572, 2004

• 13) Ueda K et al:Evaluation of muscle graft using facial nerve on the affected side as a motor source in the treatment of facial paralysis. Scand J Plast Reconstr Surg Hand Surg 33:47-57, 1999
  pubmed

• 14) Ueda K et al:Free neurovascular muscle transplantation for the treannent of faci alparalysis using the hypoglossalnerve as a recipient motor source. Plast Reconstr Surg 94:808-817, 1994

• 15) Koshima I et al:Free rectus femoris muscle transfer for one-stage reconstruction of established facial paralysis. Plast Reconstr Surg 94:421-430, 1994
  pubmed

P.28 掲載の参考文献

• 1) 松浦宏司ほか:外耳道後壁再建術の検討-特に前鼓室開放術の意義-.Otology Japan 2 (5):622-627, 1992

• 2) 春田 厚ほか:中耳根治術症例に対する外耳道後壁再建術の検討.Otology Japan 10 (5):578-582, 2000

• 3) 瀬川祐子ほか:真珠腫性中耳炎術後のMRI所見とその有用性. 日耳鼻 98 (7):1079-1085, 1995

• 4) Palva T:Reconstruction of ear canalin surgery for chronic ear. Arch Otolaryngol 75:329-334, 1962

• 5) 高橋 姿:鼓室形成術-私のコツ私の工夫-外耳道の処理. MB ENT 36:84-88, 2004

• 6) Nadol JB Jr:Causes of failure of mastoidectomy for chronic otitis media. Laryngoscope 95:410-413, 1985
  pubmed

• 7) 中野雄一:術後問題と再手術.中耳炎手術.野村恭也,本庄 巌編:外耳中耳.中山書店,東京,CLIENT 21 (4):p 303-308, 2000

P.32 掲載の参考文献

• 1) Fukuda O, Yamada A:Reconstruction of the microtic ear with autogenous cartilage. Clin Plast Surg 5:351-66, 1978
  pubmed

• 2) Brent B:Auricular repair with autogenous rib cartilage grafts:two decades of experience with 600 cases. Plast Reconstr Surg 90:355-374, 1992
  pubmed

• 3) Nagata S:A new method of total econstruction of the auricle for microtia. Plast Reconstr Surg 92:187-201, 1993

• 4) 朝戸裕貴ほか:小耳症に対する耳介挙上と外耳道形成の同時共同手術.形成外科 46:779-787, 2003

• 5) Jahrsdoerfer RA et al:Grading system for the selection of patients with congenital auralatresia. Am J Otoll 3:6-12, 1992

• 6) 朝戸裕貴:耳介形成術.新臨床耳鼻咽喉科学5巻-基本手術手技,加我君孝ほか編,中外医学社,東京,p 53-56, 2003

P.38 掲載の参考文献

• 1) Kimata Y et al:Analysis of the relationships between the shape of the re-constructed tongue and postoperative functions after subtotalor total glossectomy:Laryngoscope 113:905-909, 2003

• 2) 松浦一登ほか:挙上皮弁の広頸筋と顎二腹筋の縫合による口腔底再建.頭頸部外科 14:215-220, 2005

• 3) Kimata Y et al:Anatomic variations and technical problems of the anterolateral thigh flap:Areport of 74 cases. Plast Reconstr Surg 102:1517-1523, 1998

• 4) 木股敬裕ほか:再建外科.新癌の外科-手術手技シリーズ8, 頭頸部癌,林隆一編集,メディカルビュー社,東京,p 90-108, 2003

• 5) 木股敬裕ほか:頭頸部領域の再建-口腔・中咽頭雑誌形成外科 44:841-851, 2001

• 6) Kimata Y et all:Postoperative complications and functionalresults after total glossectomy with microvascular reconstruction. Plast. Reconstr. Surg 106:1028-1035, 2000

• 7) 三浦隆男ほか:中咽頭悪性腫瘍摘出後の再建と術後機能評価. 形成外科 37:1265-1272, 1994

• 8) Kimata Y et al:Velopharyngeal function after microsurgical re-construction of lateraland superior oropharyngeal defects. Laryngoscope 112:1037-1042, 2002

• 9) Gehanno P et al:Rehabilitation velo-phaiyngee apres buccophalyngectomie-transmaxillaire elargie a la region velo-palatine. Ann. Otolaryngol Chir. Cervicofac. (Paris) 102:135-137, 1985

• 10) 井上俊哉ほか:中咽頭側壁および軟口蓋広範囲切除例に対する再建法と術後機能頭頸部外科 9:105-109, 1999

• 11) Shapiro BM et al:Primary reconstruction of palataldefects. Otolaryngol Head and Neck Surg. 95:581-585, 1986

P.42 掲載の参考文献

• 1) Gussenbauer C:Ueber die erste durch Th. Billroth am menschen ausgefuhrte Kehlkopf-Exstirpation und die Anwendung eines kunstlichen Kehlkopfes. Archiv fur Klmische Chirurgie 17:343-356, 1874

• 2) Guttman MR:Tracheohypopharyngeal Fistulization (a new procedure for speech production in the laryngectomized patient). Trans Am Laryngol Rhinoland Otol Society 41:219-226, 1935

• 3) Conley JJ et al:A new surgicaltechnique for the vocalrehabilitation of the laryngectomized patient. Ann Otol Rhinol Laryngol 67:655-664, 1958

• 4) Asai R:Asai's new voice production method. 8th Intemational Congress of Otorhinolaryngology, 1965

• 5) Amatsu M:A new one-stage surgicaltechnique for postlaryngectomy speech. Arch Otol Rhino Laryngol 220:149-152, 1978

• 6) Amatsu M et al:Primary tracheoesophageal shunt operation for post laryngectomy speech with sphincter mechanism. Ann Otol Rhinol Laryngol 95:373-376, 1986

• 7) Singer MI et al:An endscopic technique for restoration of voice after laryngectomy. Ann Otol Rhinol Laryngol 89:529-533, 1980

• 8) Landois S:Erzeugung einer (nature-lichen) Pseudostimme bei einem Manne mit totaler Exstirpation des Kehlkopfes. Archiv fur Klinische Chirurgie 38:143-149, 1889

• 9) 橋場参生ほか:抑揚を表出できる電気式人工喉頭の製品化. バイオメカニズム19回学術講演会予稿集:27-32, 1998

• 10) 全国たばこ産業株式会社「全国喫煙者率調査」

第4章 感音難聴

P.48 掲載の参考文献

• 1) National Institutes of Health:Early identification of hearing impairment in infants and young children. NIH Consensus Statement 11:1-24, 1993
  pubmed

• 2) Joint Committee on lnfant Hearing:1994 position statement. Pediatrics 95:152-156, 1995

• 3) Mason JA et al:Universalinfant hearing screening by automated auditory brainstem response measurement. Pediatrics 101:221-228, 1998
  pubmed

• 4) White KR et al:New born hearing screening in the United States:Is it becoming the standard of care?, Spivak LG ed:Universal newbom hearing screening. Thieme, New York, p 225-255, 1998

• 5) 三科 潤ほか:新生児期の効果的な聴覚スクリーニング方法と療育体制に関する検討.平成12年度厚生科学研究 (子ども家庭総合研究事業) 報告書:207-212, 2001

• 6) Moulin A et al:Distortion product otoacoustic emissions and sensorineuralhealing loss. Audiology 33:305-326, 1994
  pubmed

• 7) Bonfils P et al:Statisticalevaluation of hearing screening by distortion product otoacoustic emissions. Ann Otol Rhinolaryngol 106:1052-1062, 1997
  pubmed

• 8) Wada T et al:Further examination of infants referred from newbom hearing screening. Acta Otolaryngol Suppl 554:17-25, 2004

• 9) 森田訓子ほか:新生児および3か月児聴覚スクリーニング-検査機種および検査時期の検討.Audiology Japan 45:102-108, 2002
  Medical*Online

• 10) 福田秀徳ほか:当科における新生児聴覚スクリーニングの検討.Audiology Japan 46:249-255, 2003

P.53 掲載の参考文献

• 1) 越川房子:音知覚の組織化,小島謙四郎編著:乳児心理学, 第五章,川島書店,東京,p 117-145, 1997

• 2) Boysson-Bardie B de:How Language Comes to Children, The MIT Press, Cambridge, Massachusetts, p 13-69, 2001

• 3) 林安紀子:声の知覚の発達,桐谷滋編:ことばの獲得,第2章,ミネルヴァ書房,京都,p 37-70, 1999

• 4) 林安紀子:音声知覚の発達,音声言語医学 46 (2):145-147, 2005
  Medical*Online

• 5) Vihman MM:Phonological Development, Blackwen Publishers, Cambridge, Massachusetts, p 98-121, 1996

• 6) Studdert-Kennedy M:Mirror neurons, vocalimitation, and the evolution of particulate speech, Stamenov M et aled:Mirror Neurons amd the evolution of Brain and Language, Jokm Bertiainins Publishing Company, Amsterdam, p 207-227, 2002

• 7) Nelson K:Language in Cognitive Development, Cambridge University Press, New York, p 292-322, 1996

• 8) Northem JL et al:Hearing in Children 5th ed., Lippincott William & Wilkins, Philadelphia, p 1-31, 2001

• 9) 内山 勉ほか:WPPSI知能診断検査による難聴幼児の早期療育効果の検討,音声言語医学 41 (2):120-129, 2000
  Medical*Online

• 10) 内山 勉ほか:12ヵ月未満の難聴児の早期療育効果について,音声言語医学 45 (3):198-205, 2004
  Medical*Online

• 11) 内山勉:盲児施設ろうあ児施設に在籍する重複障害児の実態調査ならびに重複障害児の適切な処遇に関する調査研究,こども未来財団委託研究報告書,こども未来財団,東京, 2005

• 12) 内山 勉:重複障害児,加我君孝編著:新生児聴覚スクリーニング,金原出版,東京,p 160-165, 2004

• 13) 内山 勉ほか:自閉傾向・学習障害等を合併する人工内耳装用児の療育効果.Audiology Japan 47 (5):541-542, 2004
  Medical*Online

• 14) 伊集院亮子:聴覚口話法による幼児教育を受けた聴覚障害者の追跡調査,上智大学大学院修士論文, 2005

第5章 中枢性聴覚言語障害

P.58 掲載の参考文献

• 1) Schuknecht HE Woeller RC:An experimental and clinical study of deafness from lesions of the cochlear nerve. J Laryngol Otol 69:75-97, 1955

• 2) The consensus development panel:Nationalin stitutes of health consensus development conference statement on acoustic neuroma, December 11-13, 1991. Arch Neurol 51:201-207, 1994

• 3) Prasher DK, Tun T, Brookes GB et al:Mechanisms of hearing loss in acoustic neuroma:an otoacoustic emission study. Acta Otol Laryngol 1115:375-381, 1995

• 4) Inoue Y, Ogawa K, Kanzaki J:Hearing improvement after tumor removalin a vestibular schwannoma patient with severe hearing loss. Eur Arch Otor Hino Laryngol 260:487-489, 2003

• 5) Starr A, Picton TW, Sininger Y et al:Auditory neuropathy. Brain 119:741-753, 1996
  pubmed

• 6) Kaga K, Nakamura M, Shinogami M et al:Auditory nerve disease of both ears revealed by auditory brainstem responses, electrocochleography and otoacoustic emissions. Scand Audiol 25:233-238, 1996
  pubmed

• 7) 佐藤恒正:本態性後迷路障害.Audiology Jpn 28:758-771, 1985

• 8)Harrison RV:An animal modelof auditory neuropathy. Ear Hear 19:355-361, 1998

• 9) Doyle KI, Sininger Y, Starr A:Auditory neuropathy in childhood. Layngoscope 108:1374-1377, 1998

• 10) 立木 孝,本間利美,村井和夫ほか:風邪に併発する急性感音難聴-蝸牛神経炎.日耳鼻 73:1874-1884, 1970

• 11) Schukmecht HE Donovan ED:The pathology of idiopathic sudden sensorineural hearing loss. Arch Otorhinolaryngol 243:1-15, 1986

• 12) Fischer C, Mauguiere E Ibanez V et al:The acute deafness of definite multiple sclerosis:BAEP pattems. Electroencephlogr Clin Neurophysiol 61:7-15, 1985

• 13) Yamasoba T, Sasaki K, Sakmrai M:Role of acute cochlear neuritis in sudden hearing loss in multiple sclerosis. J Neurol Sci 146:179-181, 1997

• 14) O:Reilly BJ, Burrows EH:VIII th cranialnerve involvement in sarcoidosis. J Lalyngol Otol 109:1089-1093, 1995.

• 15) Babin RW, Liu C, Aschenbrener C:Histopathology of neurosensory deafness in sarcoidosis. Ann Otol Rhinol Laiyngol 93:389-393, 1984
  pubmed

P.62 掲載の参考文献

• 1) Kaga K, Shindo M, Tanaka Y Auditory brainstem responses and nonsense monosyllable perception tests findings for patients with auditory nerve and brainstem lesions. Laryngoscope 96:1272-1278, 1986

• 2) 切替一郎,設楽哲也:いわゆる後継絡性難聴の鑑別診断.Au-dioltop 8:29-33, 1965

• 3) 切替一郎:新耳鼻咽喉科学.第1版,南山堂,東京, 1967

• 4) 加我君孝編;中枢性聴覚障害の基礎と臨床.金原出版,東京, 2000

• 5) 加我君孝:特集/中枢性聴覚障害.医学のあゆみ 200 (2):153-154, 2002

• 6) 加我君孝:聴覚誘発電位の起源.神経研究の進歩 46:110-127, 2002

P.67 掲載の参考文献

• 1) Wemick C, Friedlander C:Ein fallvon Taubheit in foige von doppelseitiger lasion des Schlafelappens. Fortschritte der medizin 1:177-185, 1883

• 2) 加我君孝:聴覚皮質中枢とその障害.東京医学 100:10-20, 1993

• 3) 加我君孝:両側聴皮質・聴放線損傷と純音聴力閾値.JOHNS 15:23-33, 1999

• 4) 加我君孝編:中枢性聴覚障害の基礎と臨床.金原出版, 2000

• 5) 加我君孝:聴覚誘発電位の起源.神経進歩 46:110-27, 2002

• 6) Kaga K et al:Auditory agnosia of children after herpes encephalitis. Acta Otolaryng 123:232-235, 2003
  pubmed

• 7) Kaga K et al:Auditory middle latency MEG of patients with un-ilateral auditory cortex lesion. Acta Otolaryng 124:376-380, 2004

• 8) Kaga et al:MEG and PET studies of a patient with auditory agnosia caused by bilaterallesions of auditory radiation Acta Otolaryng, in press

P.75 掲載の参考文献

• 1) Dax M:Lesions de la moitie gauche de l'encophale coincident avec l'ouble des signes de la pensee. (lu au Congros meridionaltenu b Montpellier en 1836) Gazette Hebdomadaire de Medecine et de Chirurgie 2 (2nd ser):259-260, 1865

• 2) Broca P:Du sibge de la faculte du langage articule dans l'hemisphere gauch du cerveau. Bull Soc Anthropol 6:377-393, 1865

• 3) Broca P:Localisation des functions cerebrales. Siege de la faculte du langage articule. Bull Soc Anthropo 14:200-208, 1863

• 4) Wemicke C:Der aphasische Symptomencomplex, Eine psychologische Studie auf anatomischer Basis. Breslau:Max Cokm & Weige It, 1874

• 5) Dejerine J:Contribution aletude anatomo-pathologique et clinique des differentes varietes de cecite verbale. Memoires de la Societe de Biologique 4:61-90, 1892

• 6) Marie P:Revision de la question de l'aphasie;La troisieme circonvolution frontale gauche ne joue aucun role specialdans la fonction du langage, Sem Med 21:241-247, 1906

• 7) Monakow C, von:Die Lokalisation im Grosshim. Wiesbaden, Bergmann, 1914

• 8) Head H:Aphasia and Kindred Disorders of Speech. 2 vols., London:Cambridge University Press, 1926

• 9) Goldstein K:Die Lokalisation in der Grosshimrinde nach den Erfahrungen am Kranken Menschen. Handbuch der Normalen und Pathologischen Physiologie. vol 10:Berlin:Springer, 600, 1927

• 10) Jackson H:On the evolution and dissolution of the nervous system.[The Croonian lectures for 1884.]Lancet 1:555-558, 649-652, 739-744, 1884

• 11) GeschWind N:The paradoxical position of Kurt Goldstein in the history of aphasia. Cortex 1 (2):214-224, 1964

• 12) Geschwind N:Disconnection syndromes in animals and man, part I and II Brain 88:237-294, 585-644, 1965

• 13) Kertesz A:Westem Aphasia Battery. Grune & Stratton, New York, 1982

• 14) 杉下守弘 (WAB失語症検査日本語版作製委員会代表):WAB 失語症検査 (日本語版) ,医学書院,東京, 1986

• 15) Lichtheim L:Ueber Aphasie. Deutsches Archiv fur klin. Medicin 36:204-268, 1885 (On aphasia. Brain 7:432484, 1885)

• 16) Wemicke C:Die neueren Arbeiten uiber Aphasie. Fortschritte der Medizin 3:824-830, 1885

• 17) Wemicke C:Die neueren Arbeiten uiber Aphasie. Fortschritte der Medizin 4:371-377, 463-482, 1886

• 18) Wemicke C:The symptomeomplex of aphasia. In;Church A (Ed.), Modem Gen Med. Diseases of the Nervous System. Appleton, New York, 1908

• 19) Mohr JP et al:Broca aphasia:Pathologic and clinicalaspects. Neurology 28:311-324, 1978

• 20) 倉知正佳,小林克治,松原六郎ほか:Wernicke失語の視床変性について.失語症研究 3:33, 1983

• 21) Naeser MA et al:Relationship between lesion extent in Wernicke's area on computed tomographic scan and predicting recovery of comprehension in Wemickes aphasia. Arch Neurol 44 (1):73-82, 1987
  pubmed

• 22) Benson DF et al:Conduction aphasia. Arch Neurol 28 (5):339-346, 1973
  pubmed

• 23) Mendez ME Benson DF:Atypicalconduction aphasia:A disconnection syndrome. Arch Neurol 42 (9):886-891, 1985

• 24) Rothmam M:Das Krankheitsbild der Lichtheimschen motorischen Aphasie (Transkortikale motorische Aphasie) . Zeit Schrift fur klinische Medizin 60:87-121, 1906

• 25) Goldstein K:Die Transkortikalen Aphasien. Ergebnisse Neurologie und Psychiatrie. G Fischer, lena, 1915

• 26) Goldstein K:Language and Language Disturbances. Grune & Stratton, New YOrk, 1948

• 27) Benson DE Geschwind N:The aphasia and related disturbances. In. Baker AB, Baker LH (Ed.), Clinical Neurology. VOl 1, Harper & Row, Llagerstown, 1977

• 28) Freedman M, Alexander MP, Naeser MA:Anatomic basis of transcorticalmotor aphasia. Neurology 34:409-417, 1984
  pubmed

• 29) Bonvicini G:Ubersubkortikalesensorische Aphasie. Jahrbucher fur Psychiatrie und Neurologie 26:126-229, 1905

• 30) Pick A:Zur Symptomatologie der linksseitigen Schlafenlappenatrophie. Monatsschrift fur Psychiatrie und Neurologie 16:378-388, 1904

• 31) Alexander MP, Hiltbronner B, Fischer R:The distributed anatomy of transcorticalsensory aphasia. Arch Neurol 46:885-892, 1989

• 32) Geschwind N, Quadfasel EA., Segarra JM:Isolation of the speech area. Neuropsychologia 6:327-340, 1968

• 33) Naeser MA, Hayward RW:Lesion localization in aphasia With cranialcomputed tomography and the Boston Diagnostic Aphasia Exam. Neurology 28 (6):545-551, 1978

• 34) Dejerine J:Sur un cas de cecite verbale avec agraphie suivi d:autopsie. C R Soc Biol 43:197-201, 1891

• 35) 杉下守弘:純粋失読および失読-失書.Clinical Neuroscience 18 (12):1400-1403, 2000

• 36) Lecours AR, Lhermitte F:The"pure form" of the phonetic disintegration syndrome (pure anarthria) Anatomo-clinicalreport of a historicalcase. Brain and Language 3 (1):88-113, 1976

• 37) Darley FL:Apraxia of speech:107 years of terminologicalconfusion. Paper read at the 44th American Speech and Hearing Association Convention, 1968

• 38) Sugishita M et al:Electropalatographic analysis of apraxia of speech in a left hander and in a right hander. Brain 110 (5):1393-1417, 1987

• 39) Kussmaul A:Disturbances of speech. Cyclop Pract Med 14:581, 1877

• 40) Schuster P, Taterka H:Beitrag zur Anatomie und Klinik der reinen Worttaubheit. Zeitschr Neurol Psychiat 105:495538, 1926

• 41) Liepmann H, Storch F:Der mikroskopische Gehirnbefund bei dem Fall Gorstelle. Monatsschrift fur Psychiatrie und Neurologie 111:115, 1902

• 42) Albert ML et al:Acase study of auditory agnosia:Linguistic and non-linguistic processing. Cortex 8 (4):427-443, 1972

• 43) Ziehl F:Ueber einen Fallvon Worttaubheit und das Lichtheim'sche Krankheitsbild der subcorticalen sensorischen A phasie. D Zeitschr Nervenheilk 8:259-307, 1896

• 44) Albert ML, Bear D:Time to mderstand. A case study of word deafness with reference to the role of time in auditory comprehension. Brain 97 (2):373-384, 1974

• 45) Geschwind N:Disconnexion syndromes in animals and man. Brain 88:237-294, 585-644, 1965

• 46) Geschwind N, Fusillo M:Color-naming defects in association with alexia. Arch Neurol 15:137-146, 1966
  pubmed

• 47) Greenblatt SH:Alexia without agraphia or hemi-anopsia. Anatomical analysis of an autopsied case. Brain 96 (2):307-316, 1973

• 48) Bastian HC:On the various forms of loss of speech in cerebraldisease. British & Foreign Med Chir Rev 49:209, 470, 1869

• 49) Trescher JE, Ford FR:Colloid cyst of the third ventricle. Report of a case:operative removal with section of posterior half of corpus callosum. Arch Neurol Psychiat 37:959-973, 1937

• 50) Gazzaniga MS, Sperry RW:Language after section of the cerebral commissures. Brain 90 (1):131-148, 1967
  pubmed

• 51) 岩田 誠,杉下守弘,豊倉康夫:脳梁膨大切断例における右半球のVisual-speech disconnexion syndromeについて.臨床神経学 13 (5):308-315, 1973

• 52) 杉下守弘:脳梁損傷によるDisconnexion Syndromes (離断症候群)-日本語の半側失読と一側性失書を中心に-.神経研究の進歩 21 (5):918-929, 1977

• 53) Sugishita M et al:Reading of ideograms and phonograms in Japanese patients after partial commissurotomy. Neuropsychologia 16:417-426, 1978
  pubmed

• 54) Gordinier H:A case of brain tumor at the base of the second left frontal circonvolution. Am J Med Sci 117:526-535, 1899

• 55) Dubois J, Hecaen H, Marcie P:Vagraphie"pure". Neuropsychologia 7:271-286, 1969

• 56) Assal G, Chopins C, Zander F:Isolated writing disorders in a patient with stenosis of the left intemalcarotid artery. Cortex 6:241-248, 1970

• 57) Crary MA, Heilman KM:Letter imagery deficits in a case of pure apraxic agraphia. Brain and Language 34 (1):147-156, 1988

• 58) Ohno T et al:Apraxic agraphia due to thalamic infarction. Neurology 54 (12):2336-2339, 2000
  pubmed

• 59) Vignolo LA:Modality-specific disorders of written language. In. by Kertesz A (Ed.), Localization in Neuropsychology. Academic Press, New York, 1983

• 60) Soma Y et al:Lexicalagraphia in the Japanese language:Pure agraphia for Karji due to left posteroinferior temporallesions. Brain 112 (6):1549-1561, 1989

• 61) 杉下守弘,山田量三,吉岡真澄:脳梁幹後半の切断例に認められた左手の失書.臨床神経学 15 (4):218-225, 1975

• 62) 杉下守弘:部分的脳梁損傷研究の現況.神経心理学 4 (1):11-15, 1988

• 63) Kertesz A:The Western Aphasia Battery (WAB) . New York:Grune & Stratton, 1982

• 64) 杉下守弘ほか:WAB失語症検査 (日本語版) .医学書院, 1986

• 65) Satz P:Incidence of aphasia in left-handers:A test of some hypothetical models of cerebral speech organization. In. Herron J (Ed.), Neuropsychology of Left-handedness. Academic Press, 189-198, 1980

• 66) Weiller C et al:The large striatocapsular infarct. A clinical and pathophysiological entity. Archives of Neurology 47:1085-1091, 1990
  pubmed

• 67) Bogousslavsky J et al:The syndrome of un-ilateral tuberothalamic artery territory infarction. Stroke 17:434-441, 1986

第6章 中耳炎

P.80 掲載の参考文献

• 1) Teele DW et al:The Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in Greater Boston:aprospective cohort study. J infect Dis 160:83-94, 1989

• 2) Hotomi M et al:Factors associated with clinicaloutcome in acute otitis media. Ann Otol Rhinol Laryngol 113:846-852, 2004

• 3) 上出洋介:小児急性中耳炎の鼓膜所見に対する病期分類の試みとその検証.耳展 46:17-30, 2003

• 4) 西村忠郎ほか:第3回耳鼻咽喉科領域感染症臨床分離菌全国サーベランス結果報告.日耳鼻感染誌 22:12-23, 2004

• 5) Tumer D et al:Acute otitis media in infants younger than two months of age:microbiology, clinicalpresentation and therapeutic approach. Pediatr Infec Dis J 21:669-674, 2002

• 6) Commisso R et al:Acute otitis media:bacteriology and bacterial resistance in 205 pediatric patients. Int J Pediatr Otorhinolaryngol 56:23-31, 2000
  pubmed

• 7) 宇野芳史:小児急性中耳炎の鼻咽腔から検出されたStrepto-coccus pneumoniaeの分子遺伝学的検討.日化学療法誌 52:68-74, 2004

• 8) 工藤典代:小児急性中耳炎が難治化しているのはなぜか.化学療法の領域 21:18. 24, 2005

• 9) 山中 昇,保富宗城:難治化する急性中耳炎難治化の要因とその対策.感染症 77:595-605, 2003

• 10) 伊藤真人:新興・再興感染症急性中耳炎耐性菌と反復性中耳炎.日耳鼻 107:500-503, 2004

• 11) 林達哉:中耳炎,鼻・副鼻腔炎に対する抗菌薬治療.小児内科 37:210-215, 2005

• 12) 工藤典代:難治性中耳炎.小児内科 37:236-240, 2005

• 13) 新木五月ほか:滲出性中耳炎に対するCO2レーザーによる鼓膜切開術の経験.耳喉頭頸 74:560-563, 2002

• 14) 宇野芳史:小児急性中耳炎における短期鼓膜換気チューブ留置術の有効性について短期鼓膜換気チューブ術と鼓膜切開の比較.Otology Japan 14:676-681, 2004

• 15) 上出洋介:米国急性中耳炎ガイドラインは本邦に適用できるか.化学療法の領域 21:33-38, 2005

P.85 掲載の参考文献

• 1) Yamanaka N, Faden H:Antibody response to outer membrane protein of nontypable Heamophilus Influenzae in otitisprone children. J Pediatr 122:212-218, 1993

• 2) Harabuchi Y et al:Nasopharyngealcolonization with nontypable Heamophilus influenzae and recurrent otitis media. J Infect Dis 170:862-866, 1994

• 3) Kodama H et al:Cellular immune response of adenoidaland tonsillar lymphocytes to the P 6 outer membrane protein of nontypeable Haemophilus influenzae in children with otitis media. Acta Otolaryngol(Stockh) 119:377-383, 1999

• 4) Takada R et al:Antibodies specific to outer membrane antigens of Moraxella catarrhalis in sera and middle ear effusions from children with otitis media with effusion. Int J Pediatr Otorhinolaryngol 46:185-195, 1998
  pubmed

• 5) Harabuchi Y et al:Serum antibodies specific to CD outer membrane protein of Moraxella catarrhalis, P6 0uter membrane protein of nontypeable Haemophilus influenzae and capsular polysaccharides of Streptococcus pneumoniae in children with otitis media with effusion. Acta Oto-Laryngologica 118:826-832, 1998
  pubmed

• 6) Harabuchi Y et al:Human milk secretory IgA antibody to nontypeable Haemophilus influenzae:Possible protective effects against nasopharyngealcolonization. J. Pediatrics 124:193-198, 1994
  pubmed

• 7) Ito M et al:Nasopharyngealpenicillin-resistant Streptococcus pneumoniae strains among young children in Japan. Otol Neurotol 23:349-52, 2002
  pubmed

• 8) 生方君子:上気道・下気道感染症における薬剤耐性菌の現状. 山中 昇ほか編:薬剤耐性菌による上気道・下気道感染症に対する治療戦略,金原出版,東京,p 1-8, 2002

• 9) 林 達哉:小児の上気道炎-薬剤耐性菌は減らせるか.感染と抗菌剤 6:279-385, 2003

• 10) 林 達哉:中耳炎,副鼻腔炎に対する抗菌薬療法-抗菌薬適正使用の有用性の実証から-.小児内科 37:210-215, 2005

• 11) Hayashi T et al:Decrease in incidence of drug-resistant pathogens in the nasopharynx when amoxicillin is used as the first-line antibiotic agent. Proceedings of the 8th lnternational Symposium for Recent Advances in Otitis Media:165-166, 2004

• 12) Stenstrom C et al:General illness and need of medical care in otitis prone children. Int J Pediatr Otor hino laryngol 29:23-32, 1994

• 13) Lanphear BP et al:Increasing prevalence of recurrent otitis media among children in the United States. Pediatrics 99:E 1, 1997

• 14) 原渕保明ほか:小児の反復性中耳炎の対策は.野村恭也ほか編:耳鼻咽喉科頭頸部外科クリニカルトレンドPart 4,中山出版,東京,p 6-9, 2004

• 15) Froom J et al:Across-national study of acute otitis media:risk factors, severity and treatment at initialvisit. Report from the lntemational Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN) . JAm Board Fam Pract 14:406-417, 2001

• 16) Schilder AG et al:Intemationalperspectives on management of acute otitis media:aqualitative review. Int J Pediatr Otorhinolaryngol 68:29-36, 2004

P.89 掲載の参考文献

• 1) 富岡幸子ほか:気管支喘息患者における難治性中耳炎.Otol Jpn 2:603, 1992

• 2) 松谷幸子ほか:気管支喘息患者の難治性中耳炎-好酸球性中耳炎-(Eosinophilic Otitis Media) .耳喉頭頸 67:712-713, 1995

• 3) Tomioka S et al:Intractable otitis media in patients with bronchial asthma (eosinophihc otitis media) . In:Sanma M. ed. Cholesteatoma and Mastoid Surgery. Rome:CIC Edizioni Intemazionali, 851-853, 1997

• 4) Iino Y et al:Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated With bronchialasthma Cln Exp Allergy 31:1135-1143, 2001

• 5) 中川尚志ほか:耳漏から好酸球が検出された中耳炎症例.耳鼻と臨床 49:415-420, 2003

• 6) 松原 篤:好酸球性中耳炎の治療.耳喉頭頚 76:190-195, 1994

• 7) Hanss JG et al:The effect of heparin and related molecules on PAF induced hyperreactivity and eosinophil infiltration in the Guinea pig. Am Rev Respir Dis 139:A 134, 1989

• 8) Seeds EAM et al:The effect of heparin and related molecules on PAF and antigen induced eosinophil infiltration in the Guinea pig. Am Rev Respir Dis 145:A 697, 1992

• 9) Motojima S et al:Toxity of eosinophilcationic proteins for Guinea pig trachealepithehum in vivo. Am Rev Respir Dis 139:A 801, 1989

• 10) Matsubara A et al:The effect of topical administration of heparin to the eosinophilic otitis media. In:Takasaka T, Yuasa R, Hozawa K, editors. Recent advances in otitis media. Bologna:Monduzzi E (litore, 403-406, 2001

第7章 内耳疾患

P.94 掲載の参考文献

• 1) Hakuba N et al:Hearing Loss and Glutamate Effiux in the Perilymph Following Transient Hindbrain Ischemia in Gerbil J Comp Neurology 418:217-226, 2000

• 2) Watanabe F et al:Hypothermia prevents hearing loss and progressive hair cell death after transient cochlear ischemia in gerbils. Neurosci 102:639-645, 2001

• 3) Morizane I et al:Transient cochlear ischemia and its effects on the stria vascularis. Neuroreport 16:799-802, 2005
  pubmed

• 4) Koga K et al:Transient cochlear ischemia causes delayed celldeath in the organ of Corti:an experimental study in gerbils. J Comp Neurology 456:105-111, 2003

• 5) Taniguchi M et al:Apoptotic hair celldeath after transient cochlear ischemia. Neuro report 13:2459-2462, 2002

• 6) Hyodo J et al::The Effect of Hypothermia in the Acute Transient Cochlear Ischemia in Gerbils. Neuro report 12:1983-1987, 2001

• 7) Hakuba N et al:AMPA/kinate glutamate receptor antagonist reduces progressive inner hair cell loss after transient cochlear ischemia. Brain Research 979:194-202, 2003

• 8) Hakmba N et al:A denovirus-mediated overexpression of a gene prevents hearing loss and progressive inner hair cellloss after transient cochlear ischemia in gerbils. Gene Ther 10:426-433, 2003

• 9) Maetani T et al:Free radicalscavenger protects against irmer hair cellloss after cochlear ischemia. Neuro report 11:1881-1884, 2003

P.99 掲載の参考文献

• 1) Li Duan M et al:Adenoviraland adeno-associated Viralvector mediated gene transfer in the guinea pig cochlea. Neuro report 13:1295-1299, 2002

• 2) Schacht J:Aminoglycoside ototoxicity:prevention in sight? Otolaryngol Head Neck Surg 118:674-677, 1998
  pubmed

• 3) Kelly TC et al:Aminoguanidine reduces cisplatin ototoxicity. Hear Res 186:10-16, 2003
  pubmed

• 4) Sinswat P et al:Protection from ototoxicity of intraperitoneal gentamicin in guinea pig. Kidney Int 58:2525-2532, 2000
  pubmed

• 5) Takumida M et al:Neuroprotection of vestibular sensory cells from gentamicin ototoxicity obtained using nitric oxide synthase inhibitors, reactive oxygen species scavengers, brain-derived neurotrophic factors and calpain inhibitors. Acta Otolaryngol 123:8-13, 2003
  pubmed

• 6) Wang Y et al:Protective effects of glial cellline-derived neurotrophic factor in ischemic brain injury. Ann N Y Acad Sci 962:423-437, 2002
  pubmed

• 7) Stover T et al:Cochlear gene transfer:round window versus cochleostomy inoculation. Hear Res 136:124-130, 1999
  pubmed

• 8) Suzuki M et al:Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity. Gene Ther 7:1046-1054, 2000
  pubmed

• 9) Ishimoto S et al:Gene transfer into supporting cells of the organ of Corti. Hear Res 173:187-197, 2002
  pubmed

• 10) Yamasoba T et al:Inner ear transgene expression after adenoviralvector inoculation in the endolymphatic sac. Hum Gene Ther 10:769-774, 1999

• 11) Suzuki M et al:Adenoviralvector gene delivery via the round window membrane in guinea pigs. Neuroreport 14:1951-1955, 2003

• 12) Yamasoba T et al:Attenuation of cochlear damage from noise trauma by an iron chelator, a free radicalscavenger and glialcellline-derived neurotrophic factor in Vivo. Brain Res 815:317-325, 1999

• 13) Yagi M et al:Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cellline-derived neurotrophic factor. Hum Gene Ther 10:813-823, 1999
  pubmed

• 14) Kawamoto K et al:Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther 9:173-181, 2004
  pubmed

• 15) Ishimoto S et al:A glucocorticoid reduces adverse effects of adenovirus vectors in the cochlea. Audiol Neurootol 8:70-79, 2003
  pubmed

P.104 掲載の参考文献

• 1) 福島邦博:内耳イオン輸送機構に起因する遺伝性難聴の病態.Otol Jpn 13:100-103, 2003

• 2) Kikuchi T et al:Gap junctions in the rat cochlea:immunohis-tochemicaland ultrastructuralanalysis. Anat Emblyol 191:101-118, 1995

• 3) Kikmchi T et al:Gap junction systems in the mammaliancochlea. Brain Res Rev 32:163-166, 2000

• 4) Kikuchi T et al:Potassium ion recycling pathway via gap junction systems in the mammalian cochlea and its interruption in hereditary nonsyndromic deafness. Medical Electron Microscopy 33:51-56, 2000
  pubmed

• 5) Lautermann J et al:Expression of the gap-junction connexin 26 and 30 in the rat cochlea. Cell Tissue Res 294:415-420, 1998
  pubmed

• 6) Xia A-P et al:Expression of connexin 31 in the developing mouse cochlea. Neuro Report 11:2449-2453, 2000

• 7) Liu XZ et al:Mutations in GJA1 (connexin 43) are associated with non-syndromic autosomalrecessive deafness. Hum Mol Genet 10:2945-2951, 2001

• 8) Kelsell DP et al:Connexin 26 mutations in hereditary nonsyndromic sensorineural deafness. Nature 387:80-83, 1997
  pubmed

• 9) Denoyelle F et al:Connexin 26 gene linked to a dominant deafness. Nature 393:319-320, 1998
  pubmed

• 10) Grifa A et al:Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet 23:16-18, 1999
  pubmed

• 11) Xia J-H et al:Mutations in the gene encoding gap junction protein β-3 associated with autosomal dominant hearing impairment. Nat Genet 20:370-373, 1998

• 12) Jun AI et al:Temporalbone histopathology in connexin 26related hearing loss. Laryngoscope 110:269-275, 2000

• 13) Cohen-Salmon M et al:Targeted ablation of connexin26 in the inner ear epithelialgap junction network causes hearing impairment and cell death. Curr Biol 12:1106-1111, 2002
  pubmed

• 14) Kudo T et al:Transgenic expression of a dominant-negative connexin26 causes degeneration of the organ of Corti and non-sylldromic deafness. Hum Mol Genet 12:995-1004, 2003
  pubmed

• 15) Teubner B et al:Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential Hum Mol Genet 12:13-21, 2003
  pubmed

P.109 掲載の参考文献

• 1) Fukuhara N:Clinicipathologicalclassification of mitochondrialmyopathies. Neurol Med Chir (Tokyo) 24:125-132, 1986

• 2) Usami S et al:Genetic and clinicalfeatures of sensorineural hearing loss associated with the 1555 mitochondrial mutation. Laryngoscope 107:483-490, 1977

• 3) Yamasoba T et al:Atypicalmuscle pathology and a survey of cismutations in deaf patients harboring a 1555 A-to-G point mutation in the mitochondrialribosomal RNA gene. Neuromuscul Disord 12:506-512, 2002

• 4) Santorelli FM et al:Maternally inherited cardiomyopathy:an a typical presentation of the mtDNA 12S rRNA gene A 1555G mutation. Am J Hum Genet 64:295-300, 1999

• 5) Shoffner JM et al:Amitochondrial DNA mutation associated with maternally inherited deafness and Parkinson's disease. Neurology Suppl 46:A 331, 1996

• 6) Yamasoba T et al:Auditory findings in patients with maternally inherited diabetes and deafness harboring a point mutation in the mitochondrialt RNALeu (UUR) Gene. Laryngoscope 106:49-53, 1996
  pubmed

• 7) Sue CM et al:Cochlear origin of hearing loss in MELAS syndrome. Ann Neurol 43:350-359, 1998
  pubmed

• 8) Yamasoba T et al:Cochlear pathology associated with mitochondrialt RNALeu (UUR) gene mutation. Neurology 52:1705-1707, 1999

• 9) Sevior KB et al:Mitochondrial A7445G mutation in two pedigrees with palmoplantar keratodema and deafness. Am J Med Genet 75:179-185, 1998
  pubmed

• 10) Tiranti V et al:Maternally inherited hearing loss, ataxia and myoclonus associated with a novelpoint mutation in mitochondrial tRNASer (UCN) gene. Hum Mol Genet 4:1421-1427, 1995
  pubmed

• 11) Ensink RJ et al:Early-onset sensorineuralhearing loss and late-onset neurologic complaints caused by a mitochondrialmutation at position 7472. Arch Otolaryngol Head Neck Surg 124:886-891, 1998

• 12) Sue CM et al:Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial DNA tRNA (Ser (UCN)) gene. Neurology 52:1905-1908, 1999

• 13) Friedman RA et al:Maternally inherited nonsyndromic hearing loss. Am J Med Genet 84:369-372, 1999
  pubmed

• 14) Li M et al:ldentification of the paramomycin-resistance mutation in the 15S rRNA gene of yeast mitochondria. J Biol Chem 257:5921-5928, 1982

• 15) Hutchin T et al:A molecular basis for human hypersensitivity to aminoglycoside antibiotics. Nucl Acid Res 21:4174-4179, 1993

• 16) Inoue K et al:Mutant mtDNA at 1555 A to G in 12S rRNA gene and hypersusceptibility of mitochondrialtranslation to streptomycin can be co-transferred to rhoo Hela cells. Biochem Biophys Res Commun 223:496-501, 1996

• 17) Yamasoba T et al:Ototoxicity after use of neomycin ear drops is unrelated to A1555G point mutation in mitochondrial DNA. J Otol Laryngol 118:546-550, 2004

• 18) Takahashi K et al:Temporalbone histopathologicaland quantitative analysis of mitochondrial DNA in MELAS. Laiyngoscope 113:1362-1368, 2003

• 19) Lindsay JR, Hinojosa R:Histopathologic features of the inner ear associated With Keams-Sayre syndrome. Arch Otolaryngo 1102:747-752, 1976

• 20) Wallace DC:Mouse models for mitochondrialdisease. Am J Med Genet 106:71-93, 2001
  pubmed

• 21) Inoue K et al:Generation of mice with mitochondrialdysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nat Genet 26:176-181, 2000

• 22) Nakada K et al:Accumulation of pathogenic delta mtDNA induced deafness but not diabetic phenotypes in mito-mice, Biochem Biophys Res Commun 323:175-184, 2004

• 23) Kujoth GC et al:Mitochondrial DNA mutations, oxidative stress and apoptosis in mammalian aging. Science (in press)

• 24) Hoya N et al:A novel animal modelof acute cochlear mitochondrial dysfunction. Neuroreport 15:1597-1600, 2004

• 25) Sinnathuray AR et al:Areview of cochlear implantation in mitochondrial sensori neural hearing loss. Otol Neurotol 24:418-426, 2003

P.113 掲載の参考文献

• 1) Gacek RR et al:Pathology of presbycusis. Int J Audiol 8:199-203, 1969

• 2) Seidman M elal:Molecular mechanism of age-related hearing loss. Ageing Res Rev 1:331-343, 2002

• 3) Johnson KR et al:A major gene affecting age-related hearing loss is common to at least ten inbred strains of mice. Genomics 70:171-180, 2000

• 4) Willott JF:Hand book of mouse auditory research:From behavior to molecular biology. CRC Press. New York, p 37-45, 2001

• 5) Jokmson KR et al:Amajor gene affecting age-related hearing loss in C57BL/6J. Hear Res 114:83-92, 1997

• 6) Lee CK:Gene expression of aging and its retardation by caloric restriction. Science 285:1390-1393, 1999
  pubmed

• 7) Bordone L et al:Calorie restriction, Sirtland metabolism:understanding longevity. Nat Rev Mol Cell Biol 298:298-305, 2005
  pubmed

• 8) Koubova J et al:How does calorie restriction work? Genes Dev 17:313-321, 2003
  pubmed

• 9) Sediman MD:Effect of dietary restriction and antioxidants on presbycusis. Laryngoscope 110:727-738, 2000

• 10) Willott JF et al:Genetics of age-related hearing loss in mice. II. Strain differences and effects of caloric restriction on cochlear pathology and evoked response thresholds. Hear Res 88:143-155, 1995
  pubmed

• 11) Pickles JO:Mutation in mitochondrial DNA as a cause of presbycusis. Audiol Neurootol 9:23-33, 2003

• 12) Kujoth GC et al:Mitochondrial DNA mutations, oxidative stress and apoptosis in mammalian aging. Science 309:481-484, 2005
  pubmed

• 13) 内閣府 (編集):高齢社会白書平成17年版 (2005) 「暮らしと社会」シリーズ.ぎょうせい,東京,p 2-8, 2005

第8章 扁桃疾患

P.120 掲載の参考文献

• 1) Ylikoski J et al:Acute tonsillitis in young men:etiologicalagents and their differentiation. Scand J Infect Dis 21 (2):169-174, 1989
  pubmed

• 2) Huovinen P et al:Pharyngitis in adults:the presence and coexistence of viruses and bacterialorganisms. Ann Intem Med 110 (8):612-616, 1989

• 3) 余田敬子ほか:目でみる耳鼻咽喉科咽頭・扁桃炎におけるヘルペス群ウイルスの検出とその臨床所見.耳喉頭頸 70 (13):872-873, 1998

• 4) Komaroff AL, Schachter J et al:Chlamydialphaiyngitis. Ann Intern Med 111 (6):537-538, 1989
  pubmed

• 5) Gerber MA et al:Opticalimmunoassay test for group A betahemolytic streptococcalpharyngitis. An office-based, multicenter investigation. JAMA 277 (11):899-903, 1997

• 6) Sauvage JP et al:Double-blind, placebo-controlled, multicentre trialof the efficacy and tolerance of nifiumic acid ('Nifluril') capsules in the treatment of tonsillitis in adults. Curr Med Res Opin 11 (10):631-637, 1990

• 7) Adam D et al:Five days of erythromycin estolate versus ten days penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group. Eur J Clin Microbiol Infect Dis 15 (8):712-717, 1996

• 8) 原渕保明ほか:【扁桃炎の治療指針について】急性咽頭・扁桃炎,口咽科 17 (2):189-195, 2005

P.125 掲載の参考文献

• 1) Lee PK et al:Pyodem as:Staphilococcous aureus, streptococcus, and other gram-positive bacteria Fitzpatrick:s dermatology in general medicine. Mc GRAW-HILL. New York, p 1856-1878, 2003

• 2) 小野友道:掌蹠膿疱症の治療-扁摘の効果について-.日本皮膚科学会雑誌 86:677-683, 1976

• 3) 原渕保明:病巣感染症と扁桃摘出術の有用性.日本医事新報 3943:37-43, 1999
  Medical*Online

• 4) Hayashi Y et al:Animalmodelof focaltonsillar infection:human tonsillar lymphocytes induce skin lesion in SCID mice. Acta Otolalyngol(Stockh) 523 suppl:193-196, 1996

• 5) 山北高志ほか:掌蹠膿疱症に対する口蓋扁桃摘出術の有効性.日本皮膚科学会雑誌 114:2319-2326, 2004

• 6) Tan RSH:Acute generalized pustular bacterid. Br J Dermato 191:209-215, 1974

• 7) Christopfers E, Mrowietz U:Pustular eruptions of palms and soles. Fitzpatrick's demlatology in generalmedicine. McGRAW-HILL. New York, p 628-632, 2003

• 8) Andrews GC et al:Recalcitrant pustular eruptions of the palms and soles. Arch Derm Syph 29:548-563, 1934

• 9) Akiyama T et al:The relationships of onset and exacerbation of pustulosis palmaris et plantaris to smoking and focalinfection. J Dermatol 22:930-934, 1995
  pubmed

• 10) 山本洋子ほか:掌蹠膿疱症における歯性病巣治療の有効性について.日本皮膚科学会雑誌 111:821-826, 2001

• 11) 高橋慎一ほか:歯性病巣感染と皮膚疾患.東京都歯科医師会雑言志 52 (4):213-220, 2004

• 12) 橋口一弘:掌蹠膿疱症症例に対する扁桃誘発試験の有用性に関する検討.口腔・咽頭科 11 (2):201-206, 1999

• 13) Wrone-Smith T, Nicoloff B:Dermalirtiection of immunocytes induces pasoriasis. J Clin Inv 98 (8):1878-1887, 1996

P.131 掲載の参考文献

• 1) Berger J, Hinglais N:Les depots intercapillaires d'IgA-IgG. J Urol Nephrol 74:694-695, 1968

• 2) 杉山信義,増田 游:慢性扁桃炎を伴うIgA腎症8例の扁摘効果.日扁桃誌 22:132-137, 1983

• 3) 厚生労働省特定疾患進行性腎障害に関する調査研究班・IgA 腎症分科会編:IgA腎症診療指針[第2版].協和企画,東京, p 1-5, 2002

• 4) Baba Y et al:Quantitative analysis of interleukin 6 (IL6) in patients with IgA nephropathy after tonsillectomy. Auris Nasus Larynx 26:177-182, 1999
  pubmed

• 5) Matsuda M et al:Increased urinary excretion of macrophagecolony-stimulating factor (M-CSF) in patients with lgA nephropathy:tonsilstimulation enhances urinary M-CSF excretion. Nephron 81:264-270, 1999

• 6) 小坂道也:IgA腎症扁摘例の長期予後-非扁摘例との腎病理所見による比較検討-.日耳鼻 101:916-923, 1998

• 7) 赤木博文ほか:IgA腎症扁摘例の10年予後.口咽科 15:335-344, 2003

• 8) Akagi H et al:Long-term results of tonsil lectomy as a treatment for lgA nephropathy. Acta Otolaryngol 555 (Suppl):38-42, 2004

• 9) 小市健一ほか:IgA腎症の扁摘効果と予後:特に腎病理組織と尿所見,腎機能の推移について.口咽科 9:329-335, 1997

• 10) Hotta O et al:Tonsillectomy and steroid pulse therapy significantly impact on clinicalremission in patients with lgA nephropathy. Am J Kidney Dis 38:736-743, 2001

• 11) Xie Y et al:The efficacy of tonsillectomy on long-term renal survivalin patients with IgA nephropathy. Kidney Int 63:1861-1867, 2003

• 12) Sato M et al:Cohort study of advanced IgA nephropathy:efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin Pract 93:137-145, 2003
  pubmed

• 13) 形浦昭克ほか:扁桃誘発試験の再評価:扁桃病巣感染症診断基準の標準化に関する委員会報告,第4報.口咽科 9:213-221, 1997

• 14) 赤木博文ほか:IgA腎症扁摘有効例の扁桃誘発試験.耳鼻臨床 90:1035-1040, 1997

• 15) 赤木博文ほか:扁桃とIgA腎症に関するアンケート調査結果. 日耳鼻 102:305. 310, 1999

P.135 掲載の参考文献

• 1) Xie Y et al:The efficacy of tonsillectomy on long-term renalsurvivalin patients with IgA nephropathy. Kidney Int 63:1861-1867, 2003
  pubmed

• 2) Hotta O et al:Tonsillectomy and steroid pulse therapy significantly impact in patients with lgA nephropathy. Am J Kidney Dis 38:736-742, 2001

• 3) Komatsu H et al:Multiple analysis of prognostic factors and effect of treatment in patients with IgA nephropathy. Ren Fail 27:45-52, 2005

• 4) Hotta O et al:Regression of IgA nephropathy:A repeat biopsy study. Am J kidney Dis 39:493-502, 2002
  pubmed

• 5) Hotta O:Use of corticosteroids, other immunosuppressive therapies and tonsillectomy in treatment of IgA nephropathy. Semin Nephrol 24:244-255, 2004
  pubmed

• 6) Horie A et al:IgAI molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. Am J Kidney Dis 42:486-496, 2003

• 7) 服部謙志:IgA腎症に対する口蓋扁桃摘出術の治療効果と長期予後予測因子.日耳鼻 101:1412-1422, 1998

• 8) Szeto CC et al:The natural history of immunoglobulin A nephropathy among patients with hematuria and minimalproteinuria. Am J Med 110:434437, 2001

• 9) 堀田 修,菊田芳克:扁桃摘出・ステロイドパルス療法.IgA 腎症診療マニュアル・改訂第2版,富野康日己編,南江堂, 東京,p 180-190, 2003

• 10) Sato M et al:Cohort study of advanced IgA nephropathy:Efficacy and limitations of corticosteroids with tonsillectomy. Nephron 93:137-145, 2003
  pubmed

• 11) Matutani S et al:Clinicalobservation of palatine tonsils in IgA nephropathy. Acta Otolaryngolsupple 555:58-61, 2004

• 12) Akagi H et al:Long-term results of tonsillectomy as a treatment for lgA nephropathy. Acta Otolaryngolsupple 555:38-42, 2004

• 13) Sato Y et al:IgA nephropathy with poorly developed lynphoepithelialsymbiosis of the palatine tonsils. Nephron 74:301-308, 1996
  pubmed

第9章 頭頸部癌

P.142 掲載の参考文献

• 1) Harrington KJ et al:Gene therapy for head and neck cancer. Cancer Metastasis Rev 24:147-164, 2005
  pubmed

• 2) Clayman GL et al:Adenovirus-mediated Wild-type p 53 gene transfer as a surgicaladjuvant in advanced head and neck cancers. Clin Cancer Res 5:1715-1722, 1999

• 3) Miller AD:Retroviralvectors. Curr Top Microbiollmmunol 158:1-24, 1992

• 4) Kanazawa T et al:Suicide gene therapy using AAVHSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice. Gene Ther 10:51-58, 2003

• 5) Gleich LL:Gene therapy for head and neck cancer. Laryngoscope 110:708-726, 2000
  pubmed

• 6) McComell MJ:Biology of Adenovirus and Its Use as a Vector for Gene Therapy. Human Gene Therapy 15:1022-1033, 2004

• 7) Moon C:Current status of gene therapy for lung cancer andhead and neck cancer. Clin Cancer Res 9:5055-5067, 2003
  pubmed

• 8) Kay MA:Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 24:257-261, 2000
  pubmed

• 9) Zhang S et al:Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release 100:165-180, 2004
  pubmed

• 10) Tsihlias J:The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu Rev Med 50:401-423, 1999
  pubmed

• 11) Xu G et al:Strategies for enzyme/prodrug cancer therapy Clin Cancer Res 7:3314-3324, 2001
  pubmed

• 12) Gomez-Navarro J et al:Gene therapy for carcinoma of the breast:Pro-apoptotic gene therapy. Breast Cancer Res 2:32-44, 2000
  pubmed

• 13) Isayeva T et al:Anti-angiogenic gene therapy for cancer. lnt J Oncol 25:335-343, 2004

• 14) Spitzweg C et al:Prostate-specific antigen (PSA) promoterdriven androgen-inducible expression of sodium iodide symporter in prostate cancer celllines. Cancer Res 59:2136-2141, 1999

• 15) Dranoff G:Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4, 11-22, 2004
  pubmed

P.148 掲載の参考文献

• 1) Tappeiner H et al:Therapeutische versuche mit fluorescieren stiffen. Munch Med Wochschr 1:2042-2044, 1903

• 2) Policard A et al:Etude sur les aspects offerts par des tumeurs experimentales examinees a la lumiere de Wood. CR Soc Biol Lyon 91:1423-1428, 1924

• 3) Lipson RL et al:The photodynamic properties of a particular haematoporphyrin derivative. Arch Dermatol 82:508-516, 1960
  pubmed

• 4) Dougherty TJ et al:Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 62:231-237, 1979
  pubmed

• 5) Wile AG et al:Photoradiation therapy of head and neck cancer. Arn J Clin Oncol 6:39-43, 1984

• 6) Crescenzi E et al:Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cyto-toxicity in MCF-7 breast cancer cells. Mol Cancer Therapeutics 3:537-544, 2004

P.153 掲載の参考文献

• 1) Argilis A et al:competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin. Cancer Res 10 (6):1956-1962, 2004
  pubmed

• 2) Grau C et al:Radiotherpy with or Without mitomycin c in the treatment of locally advanced head and neck cancer. Results of the IAEA multicenter randomized trial. Radiother. Oncol 67 (1):17-26, 2003
  pubmed

• 3) Rischin d et al:Tiraparazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer:a randomized phase II trialof the trans-tasman radiation oncology group (TROG98.02) . JClin Oncol 23:79-87, 2005

• 4) 佃 守:Chemoradiationの臨床.頭頸部癌,癌と化学療法 24 (14):2049-2057, 1997

• 5) Pignon JP et al:Chemotherapy added to locoregionaltreatment for head and neck squamous cell carcinoma:three meta-analyses of updated individual data. Lancet 355:949-955, 2000
  pubmed

• 6) Monnerat C et al:End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Annals Oncol 13:995-1006, 2002

• 7) Janinis J et al:Sequential chemotherapy with docetaxel, ciaplatin, and 5-fluorouracilin patients with locally advanced head and neck cancer. Am J Oncol 24 (3):227-231, 2001

• 8) Haddad R, Colevas AD, Tishler R et al:Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck. The Dana Farber Cancer Institute Experience. Cancer 97:412-418, 2003

• 9) Vermorken JB, Remenar E, Van Herpen C et al:Standard cisplatin/infusional 5-fluorouracil(PF) vs docetaxel(T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cellcarcinoma of the head and neck (LA-SCCHN):a phase III trialof the EORTC head aLnd neck cancer group (EORTC24971) . Proc Am Soc Clin Oncol. 23:17 (Absta. 5508), 2004

• 10) Tsukuda M, Mikami Y, Tanigaki Y et al:Phaseltrialof combined chemotherapy with docetaxel, cisplatin and 5-fluorouracilfor patients with locally advanced head and neck squamous cellcarcinoma of the head and neck. Int. J Clin Oncol 9:161-166, 2004

• 11) Pignon JP, Syz N, Posner M et al:Adjusting for patient selection suggests the addition of docetaxelto 5-fiuorouracil-cisplatin induction therapy may offer survivalbenefit in squamous cellcancer of the head and neck. Anti-Cancer Drugs 15:331-340, 2004

• 12) 佃 守:頭頸部癌化学療法の進歩.頭頸部癌化学療法の過去・現在・将来JOHNS 21 (1):5-8, 2005

• 13) Fujii M et al:Phase I/II trialof weekly docetaxeland concomitant radiotherapy for squamous cellcarcinoma of the head and neck. Int, J Clin Oncol 9 (2):107-112, 2004

• 14) 藤井博文ほか:頭頸部癌に対するtaxotere (TXT), cisplatin (CDDP) 併用第I,II相試験.日癌治 37 (2):516 (抄録PO 32-3), 2002

• 15) Katori M, Tsukuda M, Mochimatu I et al:Phase I trialof concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fiuorouracil(TPF) in patients with locally advanced squamous cellcarcinoma of the head and neck (SCCHN) . Br. J. Cancer 90 (2):348-352, 2004

• 16) Forastiere AA et al:Concurrent chemotherapy and radiotherapy fbr organ preservation in advanced laryngeal cancer. N Engl J Med 349 (22):2091-2098, 2003

• 17) Ezra EW et al:The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 22:1743-1752, 2004

• 18) Urba SG et al:Organ preservation for advanced respectable cancer of the base of tongue and hypopharynx:a southwest oncology group trial. J Clin Oncol 23:88-95, 2005

P.159 掲載の参考文献

• 1) 横山純吉ほか:二経路投与法の超選択的動注療法による集学的治療:頭頚部腫瘍 24 (3):325-333, 1998

• 2) 横山純吉ほか:超選択的動注療法による下咽頭進行癌の臓器温存療法:頭頚部腫瘍 26 (3):468-475, 2000

• 3) 横山純吉ほか:超選択的動注療法による副鼻腔進行癌の機能温存療法:癌の臨床 45:431-437, 1999
  Medical*Online

• 4) 横山純吉:超選択的動注療法による頭頚部進行癌治療時におけるCT-アンギオの有用性の検討:癌と化学療法 29 (12):2302-2306, 2002

• 5) 横山純吉:総説-頭頸部進行癌の動注療法の現状と展望-:癌と化学療法 29 (2):169-175, 2002

• 6) Yokoyama J et al:Newly two routes chemoherapy by superselective intra-arterialinfusion of high-dose cisplatin and STS for head and neck cancer;1st world congress on HEAD and NECK ONCOLOGY:1075-1079, 1998

• 7) 横山純吉:超選択的動注療法による頭頸部進行癌治療時におけるCT-アンギオの有用性の検討:癌と化学療法 29 (12):2302-2306, 2002
  Medical*Online

• 8) Kubota K et al:FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radiochemotherapy:comparison with MRI/PET. Eur J Nuclear Medicine and Molecular Imaging 31:590-595, 2004

• 9) Gouyette A et al:Pharmacokinetics of intra-arterialamd intravenous cisplatin in head and neck cancer patients. Eur J Cancer Clin Oncol 22 (3):257-263, 1986
  pubmed

• 10) Robbins KT et al:Factors predictive of localdisease controlafter intra-arterialconcomitant chemoradiation (RADPLAT) . Laryngo-scope 114 (3):411-417, 2004

• 11) Snyderman CH et al:Outcome of carotid artery resection for neoplastic disease:ameta-analysis Ame J of Otolarymg 13:373-380, 1992

• 12) Stephen F et al:Management of neck metastasis with carotid artery Involvement. Laiymgoscope 114:20-24, 2004

• 13) Collins JM:Pharmacologic rationale for regionaldrug delivery. J Clin Oncol 2 (5):498-504, 1984
  pubmed

P.163 掲載の参考文献

• 1) Fujishiro M et al:Application of endoscopic mucosalresection for hypophaiyngealcancer. Digestive Endoscopy 13 (4):220-224, 2001

• 2) 永井 鑑ほか:食道表在癌の治療戦略,食道癌に重複する下咽頭表在癌の診断と内視鏡治療.消化器内視鏡 15 (3):423-429, 2003

• 3) 渡邉昭仁ほか:気管,下咽頭・食道領域の悪性腫瘍への治療最前線,下咽頭癌内視鏡的粘膜切除術,喉頭ファイバースクリーニングの有用性.日本気管食道科学会会報 55 (2):109-113, 2004

• 4) 大森 泰ほか:気管,下咽頭・食道領域の悪性腫瘍への治療最前線,中下咽頭表在癌に対する内視鏡的粘膜切除術.日本気管食道科学会会報 55 (2):133, 2004

• 5) 武藤 学,堅田親利:上部消化管での内視鏡的治療の現況と問題点,早期癌に対する内視鏡的治療,内視鏡医による頭頸部領域の早期癌診断と治療.臨床消化器内科 19 (10):1327-1336, 2004

• 6) 井上晴洋ほか:上部消化管拡大観察の意義,食道扁平上皮癌の拡大内視鏡.胃と腸 38 (12):1629-1640, 2003

• 7) 有馬美和子ほか:消化器内視鏡-拡大観察の世界,血管像から見た表在食道病変の良悪性鑑別診断.細胞 35 (6号):210-212, 2003

• 8) 佐野 寧ほか:縮小治療のための胃癌の粘膜内浸潤範囲診断, 狭帯化RGB filter内蔵narrow band imaging (NBI) systemの開発・臨床応用.胃と腸 36 (10):1283-1287, 2001

• 9) 小倉 剛:新世代の拡大内視鏡,拡大内視鏡の機構と特長, オリンパス製拡大内視鏡の機構とその特長.消化器内視鏡 13 (3):458-463, 2001

• 10) 横山 顕ほか:アルコール依存症者の上部気道消化管癌と ADH2/AILDH2遺伝子多型との関連.アルコールと医学生物学 20:82-85, 2000

• 11) Yokoyama A et al:Alcoholand aldehyde dehydrogenase gene polymorphisms and orophaiyngolaryngeal, esophagealand stomach cancers in Japanese alcoholics. Carcinogenesis 22 (3):433-439, 2001

• 12) Inoue H et al:A new simplified technique of endoscopic esophagealmucosalresection using a cap-fitted panendoscope (EMRC) . Surg Endosc 6 (5):264-265, 1992
  pubmed

• 13) 大森 泰ほか:咽喉頭表在癌の診断と治療.耳鼻と臨床 (投稿中)

第10章 鼻アレルギー

P.169 掲載の参考文献

• 1) 鼻アレルギー診療ガイドライン作成委員会:鼻アレルギー診療ガイドライン-通年性鼻炎と花粉症-2002年版 (改訂第4版) .(株)ライフサイエンス,東京, 2002

P.174 掲載の参考文献

• 1) 朝倉光司,山本哲夫:北海道地区における花粉症とoralallergy syndrome.アレルギー・免疫 8:846-851, 2001

• 2) Eriksson NE et al:Food hypersensitivity in patients with pollen allergy. Allergy 37:437-443, 1982
  pubmed

• 3) Ortolani C et al:The oral allergy syndrome. Ann Allergy 61:47-52, 1988
  pubmed

• 4) Pauli G et al:Celery sensitivity:clinicaland immunologicalcorrelations with pollen allergy. Clinical Allergy 15:273-279, 1985

• 5) 荒井康男ほか:成人気管支喘息と食品アレルギー,第2報 Oral Allergy Syndrome-スギ花粉症との関係.アレルギー 47:715, 1998
  Medical*Online

• 6) Scheurer S et al:Cross-reactivity and epitope analysis of Pru a 1, the major cherly allergen. Mol Immunol 36:155-167, 1999

• 7) Ebner C et al:Common epitopes of birch pollen and apples studies by Westem and Northern blot. J allergy Clin Immunol 88:588-594, 1991

• 8) Daschner A et al:Specific IgE to recombinant vegetalpanallergen (rBet v 2) and fruit allergy in pollinic patients. Allergy 53:614, 1998

• 9) van Ree R et al:Pollen-related allergy to peach and apple:An important role for profilin. J Allergy Clin Immunol 95:726-734, 1995

• 10) Pastrello EA et al:Clinicalrole of a lipid transfer protein that acts as a new apple-specific allergen. J Allergy Clin Immunol 104:1099-1106, 1999

• 11) 小川 正:果物,野菜,穀物アレルゲンと植物防御タンパク質.アレルギー免疫 8:902-909, 2001

• 12) Asero R:Effects of birch pollen-specific immunotherapy on apple allergy in birch-hyperseensitive patients. Clinicaland Experimental Allergy 28:1368-73, 1998

• 13) Asero R:Fennel, cucumber, and melon allergy successfully treated with pollen-specific injection immunotherapy. Ann Allergy Asthma Immunol 84:460-462, 2000
  pubmed

P.180 掲載の参考文献

• 1) Rotrosen D et al:The immune tolerance network:Anew paradigm for developing tolerance-inducing therapies. J Allergy Clin lmmunol 110:17-23, 2002

• 2) Okano M et al:Differentialrole of CD80 and CD86 molecules in the induction and the effector phases of allergic rhinitis in mice. Am J Resp Crit Care Med 164:1501-1507, 2001
  pubmed

• 3) Kaknoki Y et al:Allergen induced mRNA expression of interleukin-5, but not of interleukin-4 and interferon-gamma, in peripheralblood mononuclear cells obtained before the pollen season predicts the clmicalefficacy of iminunotherapy for seasonalallergic rhinitis. Scand J Immunol 51:202-208, 2000

• 4) Wilson DR et al:Grass pollen immunotherapy:Symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasalmucosa during the pollen season. J Allergy Clin Immunol 107:971-976, 2001

• 5) Adkis CA et al:Role of IL-10 in allergen-specific immunotherapy and nonmalresponse to allergens. Microbes Infect 3:891-898, 2001

• 6) Savolainen J et al:Increased expression of allergen-inducedin Vitro interleukin-10 and interleukm-18 mRNA in peripheralblood mononuclear cells of anergic rhinitis patients after specific immunotherapy. Clin Exp Allergy 34:413-419, 2004

• 7) Francis JN et al:Induction of IL-10+CD4+CD25+Tcells by grass pollen immunotherapy. J Allergy Clin Immunol 111:1255-1261, 2003
  pubmed

• 8) Platts-Mills T et al:Sensitisation, asthma, and a modified Th2response in children exposed to cat allergen:apopulationbased cross-sectionalstudy. Lancet 357:752-756, 2001

• 9) Sone T et al:Tcellepitopes in Japanese cedar (Cryptomeriajaponica) pollen antigens:Choice of major T cellepitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis. J Immunol 161:448-457, 1998

• 10) Oldfield WLG et al:Effect of T-cellpeptides derived from Feld 1 on allergic reactions and cytokine production in patients sensitive to cats:a randomised controlled trial. Lancet 360:47-53, 2002

• 11) Roy K et al:Oralgene delivery with chitosan-DNA nanoparticles generates immunological protection in a murine modelof peanut allergy. Natue Med 5:387-391, 1999

• 12) Homer A et al:Optimized confugation ratios lead to allergen immunostimulatory oligodeoxyncleotide conjugates with retained immunogenicity and minimalanaphylactogenicity. J Allergy Clin lmmunol 110:413-420, 2002

• 13) Simons FER et al:Selective immune redirection in humans with ragweed allergy by injecting Amb a1 linked to immunostimulatory DNA. J Allergy Clin lmmunol 113:1144-1151, 2004

• 14) Hattori H et al:Intranasalapplication of purified protein derivative (PPD) suppresses the initiation but not the exacerbation of allergic rhinitis in mice. Clin Exp Allergy 32:951-959, 2002

• 15) Okano M et al:nasalexposure to Staphylococcalenterotoxin enhances the development of allergic rhinitis in mice. Clin Exp Allergy 35:506-514, 2005

P.185 掲載の参考文献

• 1) 鼻アレルギー診療ガイドライン作成委員会:鼻アレルギー診療ガイドライン-通年性鼻炎と花粉症-改訂第4版.ライフサイエンス・メディカ, 2002

• 2) JBousquet et al:ARIA in the pharmacy:management of allergic rhinitis symptoms in the pharmacy. Allergy 59:373-387, 2004

• 3) Bousquet J et al:Allergen immunotherapy:therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 102:558, 1998

• 4) 大橋淑宏:アレルギー性鼻炎.免疫2.186-194:最新医学社, 大阪, 2003

• 5) 大西正樹,池田正一,大塚博邦ほか:当教室における特異的減感作療法の副作用.耳鼻と臨床 37:1073-1078, 1991

• 6) Malling HJ et al:Localimmunotherapy. Allergy 53 (10):933-944, 1998
  pubmed

• 7) DR Wilson et al:Sublingualimmunotherapy for allergic rhinitis:systematic review and meta-analysis. Allergy 60:4-12, 2005

• 8) CAndre et al:Safety of sublingual-Swallow lmmunotherapy in Children and Adults. lnt Arch Allergy lmmunol 121:229-234, 2000

• 9) Dilsad Mungan et al:Comparison of the efficacy of subcutaneous and sublingualimmunotherapy in mite-sensitive patients with rhinitis and asthma-a placebo controlled study. ANNALS OF ALLERGY, ASTHMA, & IMMUNOLOGY 82:485-490, 1999

• 10) 大久保公裕ほか:スギ花粉症に対する舌下抗原特異的免疫療法-パイロットスタディー-.日鼻誌 41 (1):30-35, 2002

• 11) 盛川 宏ほか:スギ花粉症に対する舌下・嚥下免疫療法の有用性-パイロット試験と野外暴露試験による検討-.耳鼻免疫アレルギー 21 (4):33-38, 2003

• 12) 白坂邦隆ほか:スギ花粉症に対する舌下嚥下免疫療法の効果. 耳鼻免疫アレルギー 22 (4):19-23, 2004
  Medical*Online

• 13) Passalacqua G et al:Efficacy and safety of sublingualimmunotherapy. Ann Allergy Asthma Immunol 93:3-12, 2004
  pubmed

P.190 掲載の参考文献

• 1) 伊藤幸治:免疫グロブリン,宮本昭正編:臨床アレルギー学. 南江堂,東京,p 16-25, 1998

• 2) Breedveld FC:Therapeutic monoclonalantibodies. Lancet 355:735-740, 2000

• 3) Presta LG et al:Humanization of an antibody directedagainst lgE. J Immunol 151:2623-2632, 1993

• 4) Schulman ES:Development of a monoclonalanti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders. Am JRespir Crit Care Med 164:S 6-11, 2001

• 5) MacGlashan DW et al:Down-regulation of Fc (epsilon) RI expression on human basophils during in vivo treatment ofatopic patients with anti-IgE antibody. J lmmunol 158:1438-1445, 1997

• 6) Corren J et al:Effects of omalizumab, a humanized monoclonalanti-IgE antibody, on nasalreactivity to alergen and local IgE synthesis. Ann Allergy Asthma lmmunol 93 (3):243-248, 2004

• 7) Adelroth E et al:Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonalallergic rhinitis. JAIIergy Clin lmmunol 106:253-259, 2000

• 8) Casale TB:Anti-immmoglobulin E (omalizumab) therapy inseasonalallergic rhinitis. Am J Respir Crit Care Med 164:S 18-21, 2001

• 9) Kuehr J et al:Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized childrenand adolescents with seasonalallergic rhinitis. J AIIergy Clin Immunol 109 (2):274-280, 2002

• 10) http://www.fda.gov/bbs/topics/ANSWERS/2003/ANSO1236.html

• 11) http://www.fda.gov/cder/for4abeY2003/omalgenO62003LB.pdf

• 12) 荻野 敏:スギ花粉症に対する抗IgE抗体療法.日本耳鼻咽喉科学会専門医通信 83:18-19, 2005

第11章 声帯麻痺

P.195 掲載の参考文献

• 1) Li L, Oppenheim R W, Lei M et al:Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatalmouse. J Neurobiol 25:759-766, 1994

• 2) Shiotani A, O:Malley BW Jr, Coleman ME et al:Reimervation of motor endplates and increased muscle fiber size after hIGF-I gene transfer into the paralyzed larynx. Hum Gene Ther 9:2039-2047, 1998
  pubmed

• 3) Flint PW, Shiotani A, OlMalley BW Jr:IGF-1 gene transfer into denervated rat laryngealmuscle. Arch Otolaryngol Head Neck Surg 125:274-279, 1999

• 4) Shiotani A, O:Malley BW Jr, Coleman ME et al:Human insulin-like growth factor I gene transfer into paralyzed rat larynx:single vs multiple injection. Arch Otolaryngol Head Neck Surg 125:555-560, 1999
  pubmed

• 5) Nakagawa H, Shiotani A, O:Malley BW Jr et al:Timing of human insulin-like growth factor-1 gene transfer in reinnervating laryngealmuscle. Laryngoscope 114:726-732, 2004

• 6) Shiotani A, Flint PW:Myosin heavy chain composition in ratlaryngealmuscles after denervation. Laryngoscope 108:1225-1229, 1998
  pubmed

• 7) Shiotani A, Flint PW:Expression of extraocular-superfastmyosin heavy chain in rat laryngealmuscles. Neuroreport 9:3639-3642, 1998
  pubmed

• 8) Shiotani A, Jones RM, Flint PW:Postnataldevelopment ofmyosin heavy chain isoforms in rat laryngealmuscles. Ann Otol Rhinol Laryngol 108:509-515, 1999

• 9) Shiotani A, Westra WH, Flint PW:Myosin heavy chain composition in human laryngealmuscles. Laryngoscope 109:1521-1524, 1999
  pubmed

• 10) Shiotani A, Nakagawa H, Flint PW:Modulation of myosin heavy chains in rat laryngealmuscle. Laryngoscope 111:472-477, 2001

• 11) Flint PW, Nakagawa H, Shiotani A et al:Effects of insulinlike growth factor-1 gene transfer on myosin heavy chains in denervated rat laryngealmuscle. Laryngoscope 114:368-371, 2004

• 12) Saito K, Shiotani A, Watabe K et al:Adenoviral GDNF gene transfer prevents motoneuron loss in the nucleus ambiguus. Brain Res 962:61-67, 2003
  pubmed

• 13) Moro K, Shiotani A, Watabe K et al:Gene therapy to prevent nucleus ambiguous motoneuron loss. (abstract) Otolaryngol Head Neck Surg 127:P 120-121, 2002 (submitted)

• 14) Araki K, Shiotani A, Watabe K et al:Neurofunctionalrecovery after GDNF gene transfer in the recurrent laryngealnerve-injured rat. (abstract) Otolaryngol Head Neck Surg 131:P 204, 2004 (submitted)

• 15) Shiotani A, Fukumura M, Maeda M et al:Skeletalmuscle regeneration after insulin-like growth factor I gene transfer by recombinant sendai virus vector. Gene Ther 8:1043-1050, 200

P.201 掲載の参考文献

• 1) 永原國彦 神経機能再建手術1-反回神経縫合術-.JOHNS 8:1669-1673, 1992

• 2) Zealear DL et al:Controlof paralyzed axialmuscles by electricalstimulation. Acta Otolaryngol 83:514-527, 1977

• 3) Kano S et al:Pacing parameters of the canine posterior cricoarytenoid muscle. Ann Otol Rhinol Laryngol 100:584-588, 1991
  pubmed

• 4) 0bert PM et al:Use of direct posterior cricoarytenoid stimulation in laryngealparalysis. Arch Otolaryngol 110:88-92, 1984

• 5) Zealear DL et al:Electrically stimulated glottalopening combined with adductor muscle botox blockade restores both ventilation and voice in a patient with bilaterallaryngealparalysis. Ann Otol Rhinol Laryngol 111:500-506, 2002

• 6) Zealear DL et al:Reanimation of the paralyzed human laiym with an implantable electricalstimulation device. Laryngoscope 113:1149-1156, 2003

• 7) Broniatowski M, Broniatowski SG et al:Dynamic laryngealclosure for aspiration;A preliminary report. Laryngoscope 111:2032-2040, 2001

• 8) Kojima H et al:Larymgealpacing in unilateralvocalcord paralysis. An experimentalstudy. Arch Otolaryngol Head Neck Surg 116:74-78, 1990

• 9) Magoun H et al:Associated facial, vocaland respiratory components of emotionalexpression:an experimental study. J Neuro Psychopathol 17:241-255, 1937

• 10) Nonaka S et al:Brain stem neuralmechanisms for vocalization in decerebrate cats. Ann Otol Rhinol Laryngol 108:Suppl 178:15-24, 1999

• 11) Katada A et al:Functionalelectricalstimulation of laryngeal adductor muscle restores mobility of vocalfold and improves voice sounds in cats with unilateral laryngeal paralysis. Neurosci Res 50:153-159, 2004

• 12) Kidd GL:Electrical stimulation for disuse muscle atrophy. Lancet 2:1025, 1988
  pubmed

• 13) 片田彰博ほか:脱神経後の内喉頭筋萎縮に対する機能的電気刺激の効果.日気食会報 54:270-276, 2003

• 14) 荒川卓哉ほか:機能的電気刺激による内喉頭筋の筋萎縮抑制作用の発現機序の検討.喉頭 16:8-12, 2004
  Medical*Online

• 15) Otto RA et al:Functional electrical stimulation for the treatment of bilateral recurrent laryngeal nerve paralysis. Otolaryngol Head Neck Surg 95:47-51, 1986
  pubmed

P.205 掲載の参考文献

• 1) Zealear DL et al:Electricalpacing of the paralyzed human larynx. Ann Otol Rhinol Laryngol 105:689-693, 1996

• 2) Miyazaki H et al:Transcutaneous PCO (2) monitoring with hyperventilation during phonation in vocalcord paralysis, Auris Nasus Larynx 29:277-282, 2002

• 3) 岩田重信ほか:反回神経麻癖の甲状軟骨形成術後の発声機能. 耳鼻臨床 87:115-121, 1999

• 4)一色信彦:喉頭機能外科.とくに経皮的アプローチ.京都大学医学部耳鼻咽喉科同窓会, 1977
  Medical*Online

• 5) Omori K et al:Quantitative Criteria for Predictirlg Thyroplasty Tfype I Outcome. Laryngoscope 106:689-693, 1996
  pubmed

• 6) 平野 実:音声外科の基礎と臨床.耳鼻 21:239-442, 1975

• 7) 一色信彦:甲状軟骨形成術.JOHNS 9:761-766, 1993

• 8) 土師知行:甲状軟骨形成術後,シリコンブロックが喉頭内腔より排出された1例.耳鼻 45:497-500, 1999

• 9) Cotter CS et al:Larymgeal Complications after Type I Thyroplasty. Otolaryngol Head Neck Surg 113:671-673, 1995
  pubmed

• 10) 岩田重信ほか:甲状軟骨形成術の一工夫とその発声機能.音声言語医学 36:228-234, 1995

• 11) 酒井 昇ほか:甲状軟骨形成術I型の一工夫.日気食会報 44:34-37, 1993

• 12) Montgomely WW et al:MONTGOMERY(8)THYROPLASTY IMPLANT SYSTEM. Ann Otol Rhinol Laryngol 106:1-16, 1997

• 13) Meiteles LZ et al:An anatomic study of the extemallaryngealframework with surgical implications. Otolaryngol Head Neck Surg 106:235-240, 1992
  pubmed

• 14) Brandenberg JH, Unger JM, Koschkee D:Vocalcord injection with autologous fat:A long temi magnetic resonance imaging evaluation. Laryngoscope 106:174-180, 1996

第12章 睡眠時無呼吸症候群

P.210 掲載の参考文献

• 1) 宮崎総一郎,新谷朋子,三次正春:小児の睡眠時無呼吸症候群 (SAS) 小児SASの手術. MB ENT 52:印刷中, 2005

• 2) Yamadera W, Chiba S, Itoh Hiroshi, Ozone M et al:Sleep architectures of obstructive sleep apnea syndrome in the young child. Psychiatry clinical neurisciences 54:330-331, 2000

• 3) 笹村佳美,工藤典代:2歳未満で施行したアデノイド・扁桃摘出術例の検討.日耳鼻 102:1767-1770, 1999

• 4) 今野信宏,新谷朋子,渡辺一正,氷見徹夫:2歳未満のアデノイド切除,口蓋扁桃摘出術例の検討.口咽科 15(1):45, 2002

• 5) Shintani T, Asakura K, Kataura A:Evaluation of the role of adenotonsillar hypertrophy and facial morphology in children with obstmctive sleep apnea. ORL 59:286-291, 1997
  pubmed

• 6) 鈴木雅明,三枝華子:小児睡眠時無呼吸症候群.小児耳 26 (1):p 82-87, 2005

• 7) 神山 潤:睡眠の生理と臨床.診断と治療社,東京, 2003

• 8) American Thoracic Society. Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med l 53:866-878, 1996

• 9) 工藤典代:小児のいびき・睡眠時無呼吸症候群の治療.EN-TONI (1346-2067) 16 (8):59-64, 2002

• 10) 氷見徹夫:小児の扁桃摘出術.耳展 46 (5):344-350, 2003

• 11) 関 伸彦,新谷朋子,氷見徹夫:サクションコアギュレーターを用いたアデノイド切除術.口咽科 17 (2):257-263, 2005

• 12) Shintani T, Asakura K, Kataura A:The effect of adenotonsillectomy in children with OSA Int. J. Otorhinolaryngol. 44:51-58, 1998

• 13) Guilleminault C, Li KK, Khramtsov A, Pelayuo R:Sleep disordered breathing:outcomes in prepubertalchildren. Laryngoscope 114 (1):132-137, 2004

• 14) 原渕保明:小児における病態生理と対応-扁桃摘出術の適応について-.日耳鼻 105:1166-1169, 2002

• 15) 新谷朋子,朝倉光司,中野勇治,形浦昭克:小児閉塞型睡眠時無呼吸症候群難治例.耳鼻臨床 87:689-697, 1994

• 16) 新谷朋子,朝倉光司,石井 歓,吉田瑞生,形浦昭克,小笠原英樹:脳性麻痺小児における閉塞性睡眠時無呼吸.日耳鼻 101:266-271, 1998

P.216 掲載の参考文献

• 1) 睡眠呼吸障害研究会:成人の睡眠時無呼吸症候群診断と治療のためのガイドライン.メジカルビュー, 2005

• 2) 日本口腔咽頭科学会:睡眠呼吸障害ガイドライン.金原出版 (印刷中)

• 3) The report of an ASSM task force:Sleep-related brething disorders in adults:recommendations for syndrome definition and measurement techniques in clinicalresearch. Sleep 22:667-689, 1999

• 4) Cheivin RD, Aldrich MS:The Epworth Sleepiness Scale may not refiect objective measures of sleepiness or sleep apnea. Neurology. Jan;52:125-131, 1999
  pubmed

• 5) Carskadon MA:Evaluation of excessive daytime sleepiness. Neurophysiol Clin 23:91-100, 1993
  pubmed

• 6) Iwanaga K, Hasegawa K, Shibata N, Kawakatsu K, Akita Y, Suzuki K, Yagisawa M, Nishimura T:Endoscopic examination of obstnlctive sleep apnea syndrome patients during drug-induced sleep. Acta Otolaryngol Suppl 550:36-40, 2003
  pubmed

• 7) Laube DI, Gay PC, Strohl KP et al:Indications for positive airway pressure treatment of adult obstructive sleep apnea patients. Chest 115:863-866, 1999

• 8) 厚生労働省保険局医療課:老人保健福祉局老人保健課編医科点数表の解釈,社会保険研究所, 2004

• 9) Fujita S, Conway W, Zorick F et al:Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome:uvulopalatopharyngoplasty. Otolaryngol. Head Neck Surg 89:923-934, 1981

• 10) American Sleep Disorders Association Report:Practice Parameters for the Use of Laser-assisted Uvulopalatoplasty. Sleep 17:744-748, 1994

• 11) Powell NB, Riley RW, Troell RJ et al:Radio frequency volumetric tissue reduction of the palate in subjects with sleepdisordered breathing. Chest 113:1163-1174, 1998

• 12) Miyazaki S, ltasaka Y, Tada H et al:Effectiveness of tonsil lectomy in adult sleep apnea syndrome. Psychiatry and Clinical Neurosciences 52:222-223, 1998

• 13) He J, Kryger MH, Zorick FJ et al:Mortality and apnea index in obstructive sleep apnea:Experience in 385 male patients. Chest 94:9-14, 1988
  pubmed

• 14) Friedman M, Tanyeri H, Lim JW:Effect of improved nasalbreathing on obstructive sleep apnea. Otolaryngol Head Neck Surg 122:71-74, 2000

第13章 嚥下障害

P.221 掲載の参考文献

• 1) 丘村 煕:嚥下機能の評価と診断.嚥下のしくみと臨床,金原出版, 1993

• 2) 広戸幾一郎,小宮山荘太郎,渡部 宏:誤嚥の手術的治療法. 耳鼻 27:365-371, 1981

• 3) 平野 実:嚥下障害の治療-嚥下の動的障害に対する手術的治療-.耳鼻臨床 73:1667-1670, 1980

• 4) 平野 実ほか:麻痺性嚥下障害に対する手術的療法-輪状咽頭筋切断術および咽頭弁形成術-.日耳鼻 76:1067-1072, 1973

• 5) Montogomery WW:Surgery to prevent aspiration. Arch Otolaryngol 101:679-682, 1975

• 6) Baron BC, Dedo HH:Separation of the larynx and trachea for intractable aspiration. Laryngoscope 90:1927-1932, 1980
  pubmed

• 7) Linderman RC:Diverting the paralyzed larynx:Avertical procedure for intractable aspiration. Laryngoscope 85:157-180, 1975

• 8) Habal MB, Murray JE:Surgicalteatment of life-endangering chronic aspiration pneumonia. Use of an epiglottic flap to the arytenoids. Plast Reconstr Surg 49:305-311, 1972

• 9) 田山二朗:誤嚥の手術的治療.日気食会報 46 (5):387-393, 1995

• 10) Biller H F, Lawson W, Baek S:A technique of reconstruction eliminating laryngectomy. Arc Otolaryngol 109:69-73, 1983

P.224 掲載の参考文献

• 1) 藤島一郎ほか:嚥下障害ビデオシリーズ.医歯薬出版,東京, 1998

• 2) 進 武幹:X線および筋電図による食道運動の観察.日気食会報 32:83-88, 1981

• 3) Robbins J et al:Swallowing after unilateral stroke of the cortex;Preliminary experience. Dysphagia 3:11-17, 1988
  pubmed

• 4) 椿原彰夫ほか:リハビリテーションにおける嚥下障害の評価. 総合リハ 17:435-441, 1989

• 5) 丘村 煕:嚥下のしくみと臨床.金原出版,東京,p 83-111, 1992

• 6) Ali GN et al:Mechanisms of oralpharyngeal dysphagia in patients With Parknson's disease. Gastroenterology 110:383-392, 1996
  pubmed

• 7) Bushmann M et al:Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology 39:1309-1314, 1989
  pubmed

• 8) Higo R et al:Abnormalelevation of resting pressure at the upper esophageal sphincter of Parkinson's disease patients. Eur Arch Otorhinolaryngol 258:552-556, 2001

• 9) 長屋政博ほか:Videofluorographyによる脊髄小脳変性症患者の嚥下動態評価.臨床神経 35:486-491, 1995

• 10) 才藤栄一ほか:摂食・嚥下リハビリテーションマニュアル.医学書院,東京,p 108, 1996

• 11) Hellemans J et al:Pharyngoesophgeal swallowing disorders and the pharyngoesophagealsphincter. Med Clin North Am 65:1149-1171, 1981
  pubmed

• 12) Huang M-H et al:Esophageal manometric studies in patients with myasthenia gravis. J Thorac Cardiovasc Surg 95:281-285, 1988
  pubmed

• 13) Garg A et al:Radionuclide oesophageal transit time in progressive systemic sclerosis. Indian J Med Res 79:110-113, 1984
  pubmed

• 14) Lovy MR et al:Lower esophagealrings as a cause of dysphagia in progressive systemic sclerosis-coincidence or cosequence?Dig Dis Sci 28:780-783, 1983
  pubmed

• 15) Rajapakde CAN et al:Pharyngoo esophageal dysphagia in systemic sclerosis. Ann Rheum Dis 40:612-614, 1981
  pubmed

P.229 掲載の参考文献

• 1) Hillel AD et al:Bulbar amyotrophic lateralsclerosis:patterns of progression and clinical management. Head Neck 11:51-59, 1989

• 2) Strand EA et al:Management of oral-phaiyngeal dysphagia symptoms in amyotrophic lateral sclerosis. Dysphagia 11:129-139, 1996
  pubmed

• 3) Hillel AD et al:Presentation of ALS to the otolaryngologist/head and neck surgeon:getting to the neurologist. Neurology 53 (Suppl 5):S 22-25, 1999

• 4) Langmore SE:(藤島一郎監訳):嚥下障害の内視鏡的検査と治療.医歯薬出版株式会社,東京, 2002

• 5) Higo R et al:Longitudinal analysis ofprogression of dysphagiain amyotrophic lateral sclerosis. Auris Nasus Larynx 31:247-254, 2004

• 6) Higo R et al:Videomanofluorometric Study in Amyotrophic Lateral Sclerosis. Laryngoscope 112:911-917, 2002
  pubmed

• 7) Mazzini L et al:Percutaneous endoscopic gastrostomy andenteral nutrition in amyotrophic lateral sclerosis. J Neurol 242:695-698, 1995
  pubmed

• 8) Hillel AD et al:The ALS severity scale. Neuroepidemiology 8:142-150, 1989
  pubmed

• 9) MacDougall G et al:Analysis of the pharyng oesophageal pressure profile in amyotrophic lateralsclerosis. Otolaryngol Head Neck Surg 112:258-261, 1995

P.235 掲載の参考文献

• 1) 藤島一郎:脳卒中の摂食・嚥下障害.第2版,医歯薬出版, 東京, 1998

• 2) 上田 敏:リハビリテーションの思想.医学書院,東京, 1987

• 3) 藤島一郎監修:嚥下障害ビデオシリーズ(1)嚥下のビデオ内視鏡検査 (2)仮性球麻痺の訓練 (3)球麻痺患者の嚥下訓練 (4)嚥下障害における経管栄養法 (5)嚥下障害における肺理学療法 (6)嚥下食,医歯薬出版,東京, 1998, (7)嚥下造影と摂食訓練医歯薬出版, 2002, (8)口腔ケア医歯薬出版, 2004 全てをまとめた DVD版 (医歯薬出版, 2004) もある.

• 4) 聖隷三方原病院嚥下チーム:嚥下障害ポケットマニュアル, 第2版,医歯薬出版,東京, 2003

第14章 診断法

P.239 掲載の参考文献

• 1) Yamamoto T, Williamson SJ, Kaufman L et al:Magnetic localization of neuronalactivity in the human brain. Proc Natl Acad Sci (USA) 85:8732-8736, 1988

• 2) Morioka T, Mizushima A, Yamamoto T et al:Functionalmapping of sensorimotor cortex with combined use. Neuroradiology 37 (suppl):20-21, 1994

• 3) Morioka T, Yamamoto T, Katsuta T et al:Presurgicalthree-dimensionalmagnetic imaging of the somatosensory cortex in apatient with a peri-Rolandic lesion. Neurosurgery 34 (5):930-934, 1994

• 4) Minami T, Gondo K, Yamamoto T et al:Magnetoencephalographic analysis of Roland discharges in benign childhood epilepsy. A Ann Neurol 39:326-334, 1996

• 5) Gondo K, Minami T, Nagayama J et al:Case of epilepsy with speech disorders:EEG changes and magnetoencephalogra phic analysis. J. Epilepsy 10:73-77, 1997

• 6) Morioka T, Mizushima A, Ya J namoto T et al:Functional mapping of the sensorimotor cortex:combined use of magnetoen-cephalography, functional MRI, and motor evoked potentials. Neuroradiol 37:526-530, 1995

• 7) 山本智矢:脳磁図による言語知覚の研究.音声言語医学 35 (3):289-294, 1994

• 8) Morioka T, Yamamoto T, Mizushima A et al:Comparison of magnetoencephalography, functional MRI and motor evoked potentials in the localization of the sensory-motor cortex. Neurol Res 17:361-367, 1995
  pubmed

• 9) Morioka T, Shigeto H, Ishibashi H et al:Magnetic source imaging of the sensory cortex on the surface anatomy MR scanning, Neurol Res 20:235-241, 1998
  pubmed

• 10) Suk J, Ribary U, Cappell J et al:Niatomicallocalization revealed by MEG recordings of the human somatosensory cortex. Electoroenceph clin Neurophysiol 78:185-196, 1991
  pubmed

• 11) Shigeto H, R, bimatsu S, Morioka T et al:Jerk-locked back averaging and dipole source localization of magnetoencephalographic transients in a patient with epilepsia partialis continua. Electroenceph clin Neurophysiol 103:440-444, 1997

• 12) Ishibashi H, Morioka T, Shigeto H et al:Magnetoencephalographic evaluation of anterior corpus callosotomy fo intractable epilepsy in a patient with Lennox-Gaustaut syndrome. J Epilepus 11:202-207, 1998

• 13) Ishibashi H, Morioka T, Shigeto H et al:Three-dimensionallocalization of subclinicalictalactivity by magnetoencephalography:correlation with invasive monitoring Surg Neurol 50:157-163, 1998
  pubmed

• 14) 重藤寛史,加藤元博,森岡隆人ほか:脳磁図による棘波の解析.臨床脳波 4:217-221, 1996
  Medical*Online

• 15) Toyoda K, Fujishima M:Clinicalapplication of magnetoencephalography for brain infarction. Clinical Neurology 35 (12):1588-1590, 1995

• 16) Yamamoto T:Study of tone and voice recognition in human auditory cortex utilizing multi-channel SQUID. The Japan J Logopedics and Phoniatrics 35:289-294, 1994

• 17) Toyoda K, Ibayashi S, Yamamoto T et al:auditoly evoked neuromagnetic response in cerebrovascular diseases:apreiminary study J Neurol Neurosurg Psychiatry 64:777-784, 1998
  pubmed

• 18) Mizoguchi C, Kobayakawa T, Saito S, Ogawa H:Gustatory evoked corticalactivity in humans studied by simultaneous EEG and MEG recording. Chem Senses 227:629-634, 2002

• 19) 山本智矢,山下弘之,小宮山荘太郎:脳磁図を用いた口腔咽頭知覚機能の評価.口咽科 11 (3):329-334, 1999

• 20) Tonoike M, Yamaguchi M, Kaetsu I, Kida H, Seo R, Koizuka I:Ipsilateraldominance of human olfactory activated centers estimated from event-related magnetic fields measured by 122-channelwhole-head neuromagnetometer using odorant stimuli synchronized with respirations. Ann N Y Acad Sci 855:579-590, 1998
  pubmed

• 21) 松山勝哉,梅崎俊郎,安達一雄,山本智矢,小宮山荘太郎:嚥下時の大脳皮質神経活動の脳磁図による検討.耳鼻と臨床 50:67-72, 2004

P.247 掲載の参考文献

• 1) ギル・パラルディ:加藤富三監訳;図説放射線医学史.講談社,東京, 1994

• 2) 木村和衛,古賀佑彦監修:ヘリカルスキャンの基礎と臨床-連続回転型CTの応用.医療科学社,東京, 1993

• 3) 加藤良一,片田和廣,藤井直子ほか:マルチスライスCTの臨床.癌の臨床46:1040-1051, 2000

• 4) 片田和廣,藤井直子,加藤良一ほか:8列Multislice CT Ad-vanced Aquilionの臨床経験.映像情報メディカル臨時増刊 34:52-59, 2002

• 5) 片田和廣,藤井直子,中根正人ほか:神経放射線領域の三次元CT診断.総合臨床 51:827-832, 2002
  Medical*Online

• 6) 辻岡勝美:CT自由自在.メジカルビュー社,東京, 2001

• 7) 片田和廣:画像診断法の過去・現在未来-CT領域.日独医報 50:30-39, 2005

• 8) Taguchi K, Aradate H:Algorithm for image reconstnlction in multi-slice CT. Med Phys 25:550-561, 1998
  pubmed

• 9) Katada K, Fujii N, Ogura Y et al:Usefulness of isotropic volumetric data in neuroradiologicaldaignosis, in Reister MF, Takahasi M, Modic M, Bruening R (eds), Medicalradiology. Diagnostic imaging and radiation oncology. Springer-Verlag Berlin Heidelberg, p 109-117, 2001

• 10) Katada K:Characteristics of Multislice CT. JMAJ 45:175-179, 2002

• 11) 片田和廣,藤井直子,加藤良一ほか:16列Advanced Aquilion(TM)によるCT診断の変革. Medical Review 88:2-10, 2003

• 12) 小林俊光:耳管の新しい画像診断法.耳管閉鎖障害の臨床. p 46-65,笹氣出版,仙台, 2005

• 13) 吉岡哲志ほか:バルサルバ法を用いた高速1mm・8列マルチスライスCTによる耳管の描出. Otol Jpn 13:111-117, 2003

• 14) 加藤久幸,桜井一生,藤井直子ほか:被裂軟骨の三次元CT 画像について.藤田学園医学会誌 24:11-15, 2000

• 15) 旭宏,内藤健晴,藤井直子ほか:発声時のMultislice CT撮影による喉頭運動の定量的評価に関する研究.藤田学園医学会誌掲載予定

• 16) Fujii N, Takasu A, Katada K, Koga S, Ida Y, Iwata S:Auditory ossicular chain imaging by three-dimensional CT. Radiology 209 (suppl):423, 1998

• 17) 藤井直子:CT・MRIアトラス-側頭骨-. Medicina 38:102-105, 2001

• 18) 藤井直子,片田和廣ほか:最適な耳小骨MPR断面の作成法と耳小骨の角度計測.日医放会誌 64:324, 2004

• 19) 藤井直子,片田和廣ほか:CT基準面に対する耳小骨の角度計測と最適な耳小骨MPR断面作成法.日耳科会誌 14:575, 2004

• 20) Fujii N, Katada K et al:Imaging technique for obtaining optimalsections of the ossicular chain by high-resolution multiplanar reformation based on measurement of normal auditory ossicular angles. European Radiology 15 (suppl):465, 2005

• 21) 藤井直子ほか:側頭骨,副鼻腔,頭蓋底のMultidetector Heli-cal CT.高橋睦正・荒川昭彦編, Multidetector Helical CTのすべて.金原出版,東京,105-114, 2002

P.251 掲載の参考文献

• 1) 新井嘉則,橋本光二ほか:小照射野X線CTの実用機"3DX Multiimage Micro CT"の基本性能.歯科放射線 40 (2):145-154, 2000

• 2) 村上信五,渡邊暢浩ほか:中耳疾患における画像診断-進歩と将来の課題-.Otol Jpn 12:86-90, 2002

• 3) 柳原尚明,中村誠治ほか:3DX Multi-lmage Micro CTによる正常耳の画像.耳鼻臨床 95 (8):863-872, 2002

P.256 掲載の参考文献

• 1) Welling DB et al:Acoustic neuroma:Acost effective approarch. Otolaiyngol Head Neck Surg 103:364-370, 1990

• 2) Allen RW et al:Low cost high-resolution fast spin-echo MR of acoustic Schwannoma:An altemative to enhanced conventionalspin-echo MR? Am J Neuroradiol 17:1205-1210, 1996

• 3) Hermans R et al:MRI screening for acoustic neuroma without gad linium;Value of 3 DFT-CISS sequence. Neuroradiol 39:593-598, 1997

• 4) 加瀬康弘ほか:耳鼻咽喉科・頭頸部外科におけるMRIの有用性と限界.JOHNS 21:279-287, 2005

• 5) 熊川孝三:適応決定のための画像検査.人工内耳適応の実際. ENTONI 1:14-19, 2001

• 6) Schratzenstaller B et al:High-resolution three-dimentional magnetic resonance imaging of the vestibular labyrinth in patients with atypicaland intractable benign positionalvertigo. ORL 63:165-177, 2001

• 7) Fazekas F et al:MR signalabnormalities at 1. 5 T in Alz-heimer's dementia and normal aging. Am J Roentgenol 149:351-356, 1987

• 8) Tell GS et al:Relationship between balance and abnormalities in cerebralmagnetic resonance imaging in older adults. Arch Neurol 55:73-79, 1998
  pubmed

• 9) 吉田 茂ほか:CTスキャンによる椎骨動脈血流障害の検索. 日耳鼻 104:872-885, 2001

• 10) 水田啓介ほか:視運動刺激による大脳活動.Brain Medical 13:47-52, 2001

• 11) Suzuki M et al:Corticaland subcorticalvestibular response to caloric stimulation detected by functionalmagnetic resonance imaging. Brain Res Cogn Brain Res 12:441-449, 2001

P.263 掲載の参考文献

• 1) Hayes D, Jerger J:Auditory brainstem response (ABR) to tone-pips:Results in normaland hearing-impaired subj ects. Scand Audiol 11:133-142, 1982

• 2) Galambos R, Makeig S, Talmachoff PJ:A40-Hz auditory potentialrecorded from the human scalp. Proc Natl Acad Sci USA 78:2643-2647, 1981

• 3) Rickards FW, Clark GM:Steady-state evoked potentials to amplitude-modulated tones. In Nodar RH, Barer C, eds. Evoked Potentials H, Boston, MA:Butterworth, P 163-168, 1984

• 4) Kuwada S, Batra R, Maher VL:Scalp potentials of normaland hearing-impaired subjects in response to sinusoidally amplitude-modulated tones. Hearing Research 21:179-192, 1986

• 5) Picton TW, Jokmm S, Dimitrijevic A et al:Human auditory steady-state response. International J Audiol 42:177-219, 2003

• 6) Fridman J, Zappulla R, Bergelson M et al:Application of phase spectralanalysis for brain stem auditory evoked potential detection in normalsubjects and patients with posterior fossa tumors. Audiology 23:99-113, 1984

• 7) Valdez JL, Perez-Abalo MC, Manin V et al:Comparison of statisticalindications for the automatic detection of 80 Hz auditory steady-state response. Ear & Hearing 18:420-429, 1997

• 8) Cohen LT, Rickards FW, Clark GM:A comparison of steadystate evoked potentials to modulated tones in awake and sleeping humans. J Acoust Soc Am 90:2467-2479, 1991
  pubmed

• 9) Aoyagi M, Kiren T, Kim Y et al:Optimalmodulation frequency for amplitude-modulation following response in young children during sleep. Hearing Research 65:253-261, 1993
  pubmed

• 10) Aoyagi M, Kiren T, Furuse H et al:Pure-tone threshold prediction by 80-Hz amplitude-modulation following response. Acta Otolaryngol(Stockh) Suppl 511:7-14, 1994

• 11) 青柳 優,鈴木 豊,渡辺知緒,伊藤 吏:変調周波数追随反応の成立機序に関する検討.Audiology Japan 47:214-221, 2004
  Medical*Online

• 12) Aoyagi M, Kiren T, Kim Y et al:Frequency specificity of amplitude-modulation following response detected by phase spectralanalysis. Audiology 32:293-301, 1993

• 13) Iins OG, Picton PE, Picton TW:Auditory steady-state response to tones amplitude-modulated at 80-110 Hz. J Acoust Soc Am 97:3051-3063, 1995

• 14) Rance G, Rickards FW:Prediction of hearing threshold in infants using auditory steady-state evoked potentials. J Am Acad Audiol 13:236-245, 2002

• 15) Rance G, Briggs RJ:Assessment of hearing in infants with moderate to frofoumd impairment:the Melboume experience with auditory steady-state evoked potentialtesting. Ann Otol Rhinol Laryngol Suppl 189:22-28, 2002

第15章 薬剤開発に関する最新情報

P.268 掲載の参考文献

• 1) 伊藤博隆,村上信五:抗菌薬.JOHNS 9:1129-1293, 2000

• 2) 伊藤博隆:抗菌薬.耳鼻咽喉科薬物療法,野村恭也,本庄 巌編:41-115,金原出版,東京, 1990

• 3) 伊藤博隆,馬場駿吉:日常遭遇する細菌感染症と変貌とその化学療法-耳鼻咽喉科領域の領域感染症-化学療法の領域 9:35-39, 1993

• 4) 鈴木賢二:耳鼻咽喉科領域感染症.抗菌薬使用の手引き,日本感染症学会,日本化学療法,136, 協和企画,東京, 2001

• 5) 伊藤博隆,馬場駿吉:細菌感染症の変貌と化学療法-耳鼻咽喉科領域感染症.松本慶三,191-200,医薬ジャーナル社,東京, 1993

• 6) 馬場駿吉,鈴木賢二ほか:第2回耳鼻咽喉科感染症臨床分離菌.全国サベイランセス結果報告,日耳鼻感染症誌,48-63, 2000

• 7) 水島裕編集:今日の治療薬.解説と便覧,南江堂,東京, 2005

• 8) 木村 哲編集:抗菌薬の処方.羊土社,東京, 2002

• 9) 辻 明良:最近の抗菌剤の動向.抗菌薬使用の手引き,日本感染症学会,日本化学療法,136,協和企画,東京, 2001

• 10) 伊藤 肇:真菌症感染症の現況と対策.日本医師会雑誌,臨時増刊, 1993

• 11) 感染症の診断・治療ガイドライン編集委員会編修:感染症の診断・治療ガイドライン2004,日本医師会雑誌,臨時増刊, 2004268

P.273 掲載の参考文献

• 1) Skipper HE et al:Experimental evaluation of potentialanti-cancer agents. XII. On the criteria and kinetics associated with "curability" of experimental leukemia:Cancer Chemother Rep 35:1-111, 1964

• 2) Norton L et al:Predicting the course of Gompertzian growth. Nature 264:542-545, 1976
  pubmed

• 3) Norton L, Simon R:Tumor size, sensitivity to therapy, and the design of treatment schedule:Cancer Treat Rep 61:1307-1317, 1977
  pubmed

• 4) Norton L, Simon R:The Norton-Simon hypothesis revised:Cancer Treat Rep 70:163-169, 1986

• 5) Goldie JH, Coldman AJ:A mathematic modelfor relating the drug sensitivity of tumors to the spontaneous mutation rate:. Cancer Treat Rep 63:1727-1733, 1979

• 6) Galsky MD et al:Multi-lnstitutional Randomized Phase II Trialof the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in Patients With Progressive Castrate Metastatic Prostate Cancer:J Clin Oncol 23:1439-1446, 2005
  pubmed

• 7) Kelly WK et al:Phase I Study of Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer:J Clin Oncol 23:1-9, 2005

• 8) Caponigro F et al:Monoclonal antibodies targeting epidermal growth factor receptor and vascular endothelialgrowth factor with a focus on head and neck tumors:Current Opinion Oncology 17:212-217, 2005

• 9) Seiwert TY, Cohen EEW:State-of-the-art management of locally advanced head and neck cancer. British Joumalof Can-cer 92:1341-1348, 2005

• 10) Li S et al:Structuralbasis for inhibition of the epidermalgrowth factor receptor by cetuximab. Cancer Cell 7:301-311, 2005

• 11) Bonner J A et al:Cetu) dmab prolongs survivalin patients with locoregionally adavanced squamous cellcarcinoma of head and neck:A phase III study of high dose radiation therapy with or without cetuximab:J Clin Oncol 2004 ASCO Annual Meeting Proceedings:Abstract No. 5507, 2004

• 12) Vanhoefer U et al:Phase 1 study of the humanized anti-epidermalgrowth factor receptor monoclonalantibody EMD 72000 in patients with advanced solid tumors that express the epidermalgrowth factor receptor:J Clin Oncol 22:175-184, 2004

• 13) VOkes EE et al:A Phase lstudy of erlotinib and bevacizumab for recurrent or metastatic squamous cellcarcinoma of the head and neck (HNC):J Clin Oncol 2005 ASCO Annual Meeting Proceedings:Abstract No. 5504, 2005

• 14) Hurwitz H et al:Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin fbr Metastatic Colorectal Cancer:NENGL J MED 350:2335-2342, 2004

• 15) Seimiya H et al:Telomere shortening and growth inhibition of human cancer cells by novelsynthetic telomerase inhibitors, MST-312, MST-295, and MST-199. Mol. Cancer Ther 1:657-665, 2002
  pubmed

• 16) Seimiya H et al:Tankyrase las a target for telomere-directed molecular cancer therapeutics. Cancer Cell 7:25-37, 2005

• 17) Kanai Y, Endou H:Heterodimeric amino acid transporters:molecular biology and pathologicaland pharmacologicalrelevance. Curr. Drug Metab 2:339-354, 2001

P.281 掲載の参考文献

• 1) 林伸和ほか:抗アレルギー薬の分類と適応.MB Derma 88:6-12, 2004

• 2) 木村元子ほか:Th 1/Th2バランスの制御とTh2細胞の分子機構.総合臨床 63 増刊4号:40-45, 2005

• 3) Shiraishi Y et al:Prostaglandin D2-indused eosinophilic airway inflammation is mediated by CRTH2 receptor. J Pharrnacol Exp Ther 312:954-960, 2005

• 4) 第17回日本アレルギー学会春季臨床大会抄録:期待されるアレルギー疾患の治療戦略.アレルギー 54:269-271, 2005

• 5) Ohmori K et al:Properties of Olopatadine hydrochloride, a new antiallegic/antihistamine drug. Drug Res 54:809-829, 2004

• 6) 羅 智靖:抗IgE抗体 (オマリズマブ) . Molecular Medicine 40:1194-1199, 2003

• 7) 大森健守ほか:アレルギー疾患治療薬の開発状況.日薬理誌 123:335-348, 2004
  Medical*Online

• 8) 永井博弌:抗アレルギー薬.医薬ジャーナル 41:211-217, 2005

• 9) 佐野公仁夫:Th1/Th2バランス;CpGDNA治療と自然免疫治療.アレルギー・免疫 12:224-229, 2005

• 10) 大森健守ほか:開発中の鼻アレルギー治療薬.今月の治療 12:115-120, 2004

• 11) Kawamoto H et al:Increased expression of inducible nitiric oxide synthase in nasalepithelialcells in patients with allergic rhinitis. Lalyngoscope 109:2015-2020, 1999

• 12) 今井俊道ほか:抗アレルギー薬.総合臨床 52:571-578, 2003
  Medical*Online

• 13) 馬場廣太郎:鼻アレルギー関連薬剤開発に関して.アレルギー・免疫 7:332-337, 2000

• 14) 永井博弌:抗アレルギー薬の開発の変遷.アレルギー・免疫 11:1512-1520, 2004

P.286 掲載の参考文献

• 1) 羽藤直人:顔面神経麻痺.ENTONI 48:21-28, 2005

• 2) 佐藤 斎:突発性難聴以外の急性感音難聴.ENTONI 48:7-15, 2005

• 3) Wilson WR et al:The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinicalstudy. Arch Otolaryngol 106:772-776, 1980

• 4) 萩森紳一:突発性難聴.ENTONI 48:1-6, 2005

• 5) 竹田泰三:メニエール病,野村恭也ほか編:21世紀耳鼻咽喉科領域の臨床8.中山書店,東京,p 365-376, 1999

• 6) 真鍋恭弘,斉藤武久,斉藤 等:急性低音障害型感音難聴に対する異なるステロイド剤による効果の相違について.Audiology Japan 45:176-181, 2002

• 7) Ito A et al:Treatment of vestibular disorders. Acta Otolaryngol(Suppl) 481:617-623, 1991

• 8) Kinishi M et al:Acyclovir improves recovery rate of facial nerve palsy in Ramsay Hunt syndrome. Auris Nasus Larynx 28:223-226, 2001
  pubmed

• 9) 村上信五,渡邊暢浩:顔面神経麻痺.ENTONI 3:14-18, 2001

• 10) Allen DB et al:No growth suppression in children treated With the maximum recommended dose of fluticasone propionate aqueous nasalspray for one year. Allergy Asthma Proc 23:407-413, 2002

• 11) Pedersen et al:Assessing the effect of intrarlasalsteroids on growth. J Allergy Clin Immunol 108 (1 Suppl):S 40-44, 2001

• 12) 小岩哲夫,鈴木秀明,鈴木直弘ほか:アレルギー性鼻炎のエアロゾル療法-局所ステロイド剤を中心に-.耳展 47 (補 1):28-32, 2004

• 13) 春名真一:好酸球性副鼻腔炎の手術的治療.ENTONI 34:50-56, 2004

• 14) 伊賀立二ほか:ステロイド製剤.薬局 54 (別冊):68-88, 2003

• 15) 門田佳子,加賀谷肇:ステロイド剤の内服.薬局 54:83-90, 2003

第16章 人工聴器

P.288 掲載の参考文献

• 1) 竹下正明:両耳人工内耳装用の経過とその効果について.福祉「真」時代.No.116:20, 2002

• 2) Muller J et al:Speech understanding in quiet and noise im bilateralusers of the MED-EL COMBI 40/40 + cochlear implant system. Ear and Hearing 23:198-206, 2002

• 3) Schoen F et al:Sound lateralization and sensitivity to interauralcues in bilateralusers of th MED-EL Comb:40/40 + Cochlear implant system. Otol & Neurotol 26:429437, 2005

• 4) Flynn M C et al:成人症例における人工内耳装用耳の対側耳への補聴装用効果.オーティコン情報, 2005

P.291 掲載の参考文献

• 1) 加我君孝:人工内耳Cochlear Implant (CI) の現在とAuditory Brainstem Implant (ABI) の未来.脳神経 51:103-114, 1999

• 2) 加我君孝:NF2 と Auditory Brainstem Implant. Current Insights in Neurological Science 9:10-11, 2000

• 3) 熊川孝三:人工聴覚治療の最新動向.日本医事新報 No.4173:10-16, 2004

• 4) Otto SR, Brackniann DE, Hitselberger WE, Shannon RV, Kuchta J:Multichannelauditory brainstem implant:update on performance in 61 patients. J Neurosurg 96:1063-1071, 2002

• 5) Hochmair E:Auditory brainstem implants using high rate multicharmel pulsatile stimulation Otol Jpn 10:559-569, 2000

• 6) 加我君孝:聴覚大脳インプラントは可能か-聴皮質の解剖と電気生理の視点から-耳喉頭頸77:194-200, 2005

P.296 掲載の参考文献

• 1) 河野康徳:適正な補聴器普及のための供給システムに関する調査研究 (3年次報告書) .補聴器供給システムの在り方研究会,東京,p 45-78, 2004

• 2) Boymans M et al:Clinicalevaluation of a full-digitalin the ear hearing instrument. Audiology 38:99-108, 1999

• 3) Knebel SB, Bentler RA:Comparison of two digitalhearing aids. Ear Hear 19:280-289, 1998

• 4) Jack JW et al:Transcranialcontralateralcochlear stimulation in unilateraldeafness. Otolaryngol Head Neck Surg 129:248-254, 2003

• 5) Claudia P et al:Bilateralbone-anchored hearing aids (BA-HAs):an audiometric evaluation. Laryngoscope 114:77-84, 2004

• 6) 岩崎聡:特集聴力改善手術:人工中耳・2) BAHA.耳候頭頸 77 (5):149-160, 2005

• 7) Cooper HR et al:The Birmingham bone anchored hearing aid programme:referrals, selection, rehabilitation, philosophy and adult results. J Laryngol Otol 110 (suppl 21):13-20, 1996

• 8) Manohar B et al:A comparison of the audiolometric perfomance of bone anchored hearing aids and air conduction hearing aids. Otol Neurootol 23:912-919, 2002

• 9) 岩崎聡ほか:埋め込み型骨導補聴器 (BAHA) と従来型補聴器との補聴効果の比較.日耳鼻 (投稿中)

• 10) Vincent C et al:Alongitudinalstydy on postoperative hearing thresholds with the Vibrant Soundbridge device. Eur Arch Otorhinolaryngol 261:493-496, 2004
  pubmed

第17章 ナビゲーションサージェリー

P.299 掲載の参考文献

• 1) 大橋元一郎,神尾正巳,阿部俊昭,鴻 信義,春名眞一:ナビゲーションシステムを用いた内視鏡下経鼻的下垂体手術. 脳神経外科ジャーナル 10:326-329, 2001

• 2) 星地亜都司,北川知明,中島 勧,竹下克志,岩崎元重ほか:コンピュータナビゲーションガイド下の胸椎前方除圧固定術.臨整外 37:519-523, 2002

• 3) 竹内直信,前田陽一郎,近藤健二,石本晋一,山岨達也ほか:Navigation systemの適応と問題点-内視鏡下鼻内手術に関して-耳展 44:394-396, 2001

P.301 掲載の参考文献

• 1) 大久保公裕ほか:アレルギー性鼻炎に対する下鼻甲介粘膜高周波電気凝固術.日鼻誌 38:111-116, 1999

• 2) 石尾健一郎ほか:内視鏡下鼻内涙嚢鼻腔吻合術.JOHNS 16 (1):111-116, 2000

技術資料編

P.306 掲載の参考文献

• 1) 伊福部 達:音の福祉工学.コロナ社,p 179-181, 1997

• 2) 須貝保徳:山越憲一編;健康・福祉工学ガイドブック.p 392-401, 2001

P.311 掲載の参考文献

• 1) PJ. Jastreboff, M. M. Jastreboff:Tinnitus Retraining Therapy (TRT) as a Method for Treatment of Tinnitus and Hyperacusis Patients. J Am Acad Audiol 11:162-177, 2000

• 2) C. W. Newman, G. P Jacobson, J. B. Spitzer:Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg 122:143-148, 1996

• 3) 関谷芳正,松田太志,高橋真理子ほか:耳鳴りに対する新しい治療法・TRT (療法) .耳鼻臨床 95 (6):639-646, 2002

• 4) 新田清一,小川 郁,井上泰宏ほか:耳鳴りの心理的苦痛度・生活障害度の評価法に関する検討. 日本聴覚医学会 Vol.45:685-691, 2002

• 5) 松田太志,関谷芳正,高橋真理子ほか:Tinnitus Retraming Therapyによる耳鳴り治療 (その2) . 日本聴覚医学会 Vol.45:671-679, 2002

P.314 掲載の参考文献

• 1) Geibel A:Applying signal statistic alanalysis to TEOAE measurements. Scand Audiol 30 (Suppl 52):130-132, 2001

• 2) Meier S et al:Comparison of currently available devices designed for newborn hearing screening using automated auditory brainstem and/or otoacoustic emission measurements. Int J Pediatric Otorhinolaryngology 68:927-934, 2004
  pubmed

P.317 掲載の参考文献

• 1) Kato M et al:Pharmacokinetic and pharmacodynamic evaluation of centraleffect of the novelanti-allegic agent betotastine besilate, Arznehnettel-Forschung/T) rug Research 47 (II) 10:1116-1124, 1997

• 2) 鵜飼幸太郎ほか:新規抗アレルギー剤ベシル酸ベトタスチン (TAU-284) の臨床薬理試験-鼻汁中好酸球および鼻腔開存度に対する影響-.臨床薬理13 (5):1401-1412, 1997

• 3) 神沼修ほか:Biologocal & Pharmaceutical Bulletin 21 (4):441, 1998

• 4) Yokota H, Mizuuchi H, Maki T, Banno K:Phase I study of TAU-284 single oral administration in healthy male volunteers. J Clin Therapeut Med, 13:1137-1153, 1997

• 5) Nakahara T, Urabe K, Moroi Y, Morita K, Furue M:Bepotasutine besilate rapidly inhibits miteantigen induced immediate reactions in atopic dermatitis. J Dermatol Sci 25:59-63, 2001

• 6) 古江増隆:ベシル酸ベポタスチンの即効性について,中原剛史,師井洋一,占部和敬:臨牀と研究. 大道学館,福岡,p 157-160, 2004

• 7) Frue M, Terao H, Koga T:Effects of cetirizine and epinastine on the skin response to histamine iontophoresis. J Dermatol Sci 25:59-63, 2001

• 8) Morita K, Koga T, Moroi Y, Urabe K, Frue M:Rapid effects of olopatadine hydrochloride on histamine-induced skin response. J Dermatol 29:709-712, 2002

• 9) 馬場廣太郎:全国801名の花粉症患者の意識調査結果報告〜花粉症患者の薬剤に対する期待〜:アレルギー&免疫.医薬ジャーナル社,大阪,p 90-95, 2004

P.319 掲載の参考文献

• 1) He J et al:Mortality and apnea index in obstructive sleep apnea-Experience in 385 male patients. Chest 94:9-14, 1988
  pubmed

• 2) Sassani A, Findley LJ et al:Reducing Motor-Vehicle Collisions, Costs, and Fatalities by Treating 0bstructive Sleep Apnea Syndrome. Sleep 27:453-458, 2004
  pubmed

P.323 掲載の参考文献

• 1) Rance G et al:Steady-state evoked potentialand behavioral hearing thresholds in a group of children with absent click-evoked auditory brain stem response. Ear and Hearing 19 (1):48-61, 1998

• 2) Rance G et al:The automated prediction of hearing thresholds in sleeping subjects using auditory steady-state evoked potentials. Ear and Hearing 16 (5):499-507, 1995
  pubmed

P.327 掲載の参考文献

• 1) 新井嘉則ほか:小照射野X線CTの実用機"3DX Multiimage Micro CT"の基本性能.歯科放射線 40 (2):145-154, 2000

• 2) 本田和也ほか:新型小照射野コーンビームCT (3DX) の基本性能.断層映像研究会雑誌 27 (4):193-198, 2000
  Medical*Online

• 3) Intemational Electrotechnical Commission:IEC 60601-2-44:Medicalelectricalequipment-Part 2-44:Particular requirements for the safety of X-ray equipment for computed tomography 9, 2001

• 4) (社) 日本アイソトープ協会:CTにおける患者線量の管理ICRP Publication 86, 2004

P.331 掲載の参考文献

• 1) 長田光博,葛西洋一,櫻井靖久,竹本忠良,西坂 剛ほか:レーザーの臨床.メディカルプランニング,札幌,P 56-73, 1981

• 2) 加藤順二,粟津邦男,篠木 毅,守矢佳世子:一からわかるレーザー歯科治療.医歯薬出版株式会社,東京,p 10-31, 2003

• 3) 渥美和彦,大森清一,坂本正一,西坂 剛,佐野圭司ほか:レーザー医学.中山書店,東京,p 131-142, 1980

P.335 掲載の参考文献

• 1) Elisabeth Hultcrantz:Elisabeth Ericsson, CRNA, BScN:Pediatric Tonsillotomy with the Radiofrequency Technique:Less Morbidity and Pain. The Laryngoscope 114:871-877, 2004

• 2) 高見昌司:Radiosurgeryの基本.日本臨床ラジオ波手術研究会ジャーナル 2-1:14, 2004

• 3) 大久保公裕:高周波電気メス.耳鼻咽喉科診療プラクティス 1:114-117, 2000